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Nucleic acid delivery  
Over the past two decades, nucleic acid delivery has shown tremendous promise 
and gained significant attention as a potential method for treating both genetic and 
acquired diseases, including severe combined immunodeficiency [1], cystic fibrosis 
[2], Parkinson’s disease [3], cancer [4], and acquired immune deficiency syndrome 
(AIDS) [5]. The importance of nucleic acid delivery for disease treatment is reflected 
in the plethora of clinical trials in the scientific literature, which in 2009 exceeded 
1500 [6]. A common approach to nucleic acid delivery has been to transfect cells with 
plasmid DNA designed to replace a defective gene in the target cell genome. 
Alternatively, RNA interference has emerged as a novel therapeutic pathway by 
which harmful genes can be "silenced" by complementary short interfering RNA 
(siRNA). The advantages of siRNA are the potent, specific inhibition of selected 
proteins. Moreover, siRNA acts primarily in the cytoplasm, which is easier to access 
than the nucleus, thus avoiding the nuclear barrier, a major obstacle of plasmid DNA 
delivery [7]. 
Today, there are many siRNA formulations in animal studies or preclinical phases at 
many major pharmaceutical companies, who are developing these novel siRNA 
therapeutics. In addition, some siRNA therapeutics are showing progress in the clinic 
(please see Table 1 [adapted from 8]). Many of the most advanced trials rely on 
forms of localized delivery.  Such a methodology offers several benefits, including the 
potential for both higher bioavailability due to the proximity of the target tissue and 
reduced unfavourable distribution typically associated with systemic administration 
[8]. The most advanced clinical trials currently underway are specifically focusing on 
the treatment of age-related macular degeneration (AMD). Here, naked siRNA 
targeting to genes against the vascular endothelial growth factor (VEGF) or its 
receptor (VEGFR) has shown therapeutic potential in its inhibition of the excessive 
vascularization of the eye that leads to AMD [9] and has already reached phase III 
clinical trials in humans [6]. 
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Table 1: Current clinical trials for siRNA therapeutics [adapted from 8]   
Company Disease Mode of 
administration 
Status Preclinical 
reference 
Allergan Age-related macular 
degeneration 
Topical Phase II 
 
[10] 
Alnylam Respiratory syncytial virus 
Cancer 
Local/direct 
Systemic 
Phase II 
Phase I 
[11] 
[12, 13] 
Nucleonics Hepatitis B virus Systemic Phase I  
Quark /Pfizer Acute renal failure Systemic Phase I  
Tekmira Hypercholesterolemia Systemic Phase I [14, 15] 
Opko Health Age-related macular 
degeneration 
Topical Phase III 
 
[16] 
Silence/Quark
/Pfizer 
Diabetic macular oedema Topical Phase II  
Transderm Pachyonychia congenita Topical Phase Ia/b [17, 18] 
Calando Cancer (solid tumor) Systemic Phase I [19] 
 
RNAi discovery and mechanism 
The effects of RNA interference (RNAi) were first reported by Napoli et al. [20] in 
1990, as a result of their attempt to overexpress chalcone synthetase (CHS), an 
enzyme largely responsible for plant coloration in petunias. The authors were 
surprised that the introduction of this gene blocked pigment synthesis, which caused 
the growth of white or partly white flowers instead of the normal purple phenotype 
[21, 22]. Although not fully understood at the time, an explanation for this result and 
other similar phenomena was revealed by Fire and Mello in 1998 when they 
discovered that the gene expression in the nematode Caenorhabditis elegans (C. 
elegans) can be silenced by delivering long, double-stranded RNAs (dsRNAs) [23].  
This method of RNAi uses the long, double-stranded RNAs that are delivered to cells 
or expressed intracellularly from plasmids. These RNAs are processed into short 21–
23 base pair (bp) fragments called small interfering RNAs (siRNAs) by an 
endogenous  RNase III-type enzyme known as  Dicer [24,25] (Figure 1). Thereafter, 
each siRNA molecule is loaded into an RNA-induced silencing complex (RISC). 
Argonaute 2 (Ago2) which is an enzymatic component of RISC, cleaves and discards 
one strand (passenger or sense strand) of the siRNA and retains the other (guide or 
antisense strand) to activate the mature RISC complex [26, 27]. Then the siRNA 
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guide strand directs the RISC to mRNA molecules containing a complementary 
nucleic acid sequence. Through Watson–Crick base pairing, the siRNA guide strand 
binds to the complementary portion of the mRNA molecule and the endonuclease 
region of RISC cleaves the mRNA in this region of homology. The cleaved mRNA, 
which is subsequently degraded by intracellular nucleases, is no longer available for 
translation of the corresponding protein. By this mechanism, long dsRNAs are able to 
induce gene silencing with very high specificity. 
 
 
Figure 1: Mechanism of RNAi: The doubled-stranded RNA is cleaved into shorter fragments 
of 21-23 base pair siRNA by the enzyme Dicer. A multiprotein complex called RISC (RNA-
induced silencing complex) combines with the siRNA, retaining the guide strand and 
discarding the passenger strand. The siRNA then guides RISC to the homologous mRNA. 
RISC-associated endonuclease cleaves the target mRNA resulting in the silencing of the 
target gene. 
 
For therapeutic purposes, siRNA can be synthetically produced and then directly 
introduced into the cells, thereby circumventing the Dicer mechanism (Figure 1). This 
shortcut reduces the potential for an innate immune interferon response and the 
shutdown of cellular protein expression that can occur following the interaction of 
long pieces (>30 nucleotides) of double stranded RNA with intracellular RNA 
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receptors [28-30]. Since the RNAi machinery is available in every cell and any gene 
can be targeted [31-33], this process cannot only be exploited to investigate gene 
function in eukaryotic cells, but it also holds great potential for suppressing the 
expression of disease-related genes [34-37].  
 
siRNA delivery 
One of the primary challenges of siRNA-based therapeutics is their delivery to cells 
[38]. The major limitations for the use of siRNA, both in vitro and in vivo, are the 
inability of naked siRNA to passively diffuse through cellular membranes due to its 
high molecular weight (~13 KDa) and the strong anionic charge of its phosphate 
backbone, which causes electrostatic repulsion from the anionic cell membrane 
surface [39]. Furthermore, fast degradation by endogenous enzymes and the lack of 
targeting ability limits the delivery of siRNA [36, 40]. Therefore, the success of siRNA 
applications depends upon the use of suitable carriers for delivery. The therapeutic 
application of siRNA requires the development of carriers that will protect siRNA from 
degradation during circulation [41], deliver the siRNA to the target cells while 
avoiding non-target cell types, facilitate cellular uptake, and release the siRNA 
intracellularly so that it will be accessible to the cellular RNAi machinery [42]. 
Numerous delivery strategies, both viral and nonviral, have been developed to 
circumvent the aforementioned problems, and some of them have been successfully 
used for the introduction of siRNA into cells both in vitro and in vivo [43, 44]. 
Viral vectors are highly efficient delivery systems due to the inherent ability of viruses 
to transport genetic material into cells; they are currently the most powerful tool for 
gene transfection. Unfortunately, fundamental problems exist with viral vector 
transfection, including high production cost, difficulties in large scale production, and, 
most importantly, severe safety risks arising from their oncogenic potential and 
inflammatory and immunogenic effects, which prevent repeated administration to 
patients [45-48]. In the light of these concerns and limitations, non-viral carriers have 
emerged as a promising alternative for siRNA delivery both in vitro and in vivo [37, 
49-53]. They have a number of advantages, including increased stability and safety, 
relatively low production cost, and the possibility of modification via the incorporation 
of ligands, aiding cell type specific targeting. However, the regulatory effect over 
gene expression levels by these carries is lower when compared with viral vectors.  
Non-viral carries still suffer from their own limitations, including high toxicity and the 
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inability to overcome the numerous biological barriers of the extracellular 
environment after local and systemic application [54, 55]. 
In non-viral delivery approaches, the double-stranded siRNA is either nacked, 
chemically modified [56, 57], or covalently attached to other molecules to enhance its 
stability. This siRNA is then complexed with a carrier material that binds to the siRNA 
via electrostatic interactions to form particles. These particles usually range in size 
from nano- to micrometers, depending on the physical characteristics of the material 
and the formulation conditions [40]. The resulting particle should protect the siRNA 
from degradation in the circulatory system, bring the siRNA into the target tissue, 
enter the cell through endocytosis, and release the siRNA in the cytoplasm. The 
formulation of nanoparticles used for in vitro and in vivo delivery of siRNA  via either 
systemic and/or local administration has exploited various kinds of materials, 
including cationic lipids (liposomes), polymers, covalently conjugated polymers to 
siRNA, peptides, proteins (including antibodies), and inorganic nanoparticles such as 
quantum dots [29,58-63]. Table 2 represents some examples of non-viral carries 
used for siRNA delivery both in vitro and in vivo. This table reveals that different 
materials, either synthetic or naturally occurring, can be complexed with siRNA and 
deliver the siRNA to various cell lines. However, the table also demonstrates that the 
size of the siRNA complexes and the different carrier materials have a high variation 
in the particle size distribution. 
Among various delivery systems, cationic polymers have gained a prominent position 
over other system for siRNA delivery, due to their ease of preparation, purification 
and chemical modification to meet the particular needs of siRNA delivery [91-96]. Of 
the many cationic polymers, poly(ethylene imine) (PEI) has been extensively 
investigated for its ability to transport siRNA into cells both in vitro and in vivo [97-
100]. 
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Table 2: Some examples of non-viral vectors for siRNA delivery 
siRNA Delivery system Diameter 
(nm) 
Type Targeted 
mRNA/tissue/ 
diseases 
Refs. 
Liposomes and Lipids 
    
DOTAP (1,2 Dioleoyl-3 
trimethylammonium-propane) 
Not 
shown 
Cationic 
liposomes 
Various cell types 
(mouse in vivo) 
[64] 
DOTAP/DOPE (1,2-dioleoyl-sn-glycero-3 
phosphatidylethanolamine) 
Not 
shown 
Cationic 
liposomes 
Targeting the 
luciferase mRNA 
in mouse L- cells 
[65] 
DOPE/CDAN (N-cholesteryloxycarbonyl-
3,7-diazanonane-1,9-diamine) 
300-500 Liposomes HeLa and IGROV-
1 cells 
[66] 
SNALP(stable nucleic acid lipid particles)  Cationic lipid 
nanoparticles 
Targeting apoB 
gene in mice 
[67] 
DOPC (1,2-dioleoyl-sn-glycero- 3 
phosphatidylcholine) 
65 Neutral 
nanoliposome 
EphA2 in mice [68] 
Polymers 
    
P(MDS-co-CES) poly 
{(Nmethyldietheneamineseacate) co 
[(cholesteryloxocarbonylamidoethyl) 
methylbis(ethylene)ammoniumbromide] 
seacate} 
175 Cationic core-
shell 
nanoparticles 
MDA-MD-231 
human breast 
cancer cells 
 
[69] 
Poly(ethylene glycol)-block-poly(aspartic 
acid) (PEG-PAA) with calcium phosphate 
100-300 Poymer 
nanoparticles 
HeLa cells [70] 
MPEG/PCL(Methoxy(polyethyleneglycol) 
/poly(ε-caprolactone) 
150 Di-block co-
polymeric 
nanoparticles 
Not shown [71] 
Chitosan 200-500 Cationic 
polysaccharide 
nanoparticles 
H1299 human 
lung carcinoma 
cells 
CHO K1 and HEK 
293 cell lines 
[72,73] 
Polyisobutylcyanoacrylate 
 
325 Noncationic 
aqueous-core 
nanocapsules 
Ewing sarcoma 
(metastatic bone 
cancer) 
[74] 
Hyaluronic acid 200-500 Nanogel HCT116 human 
colon carcinoma 
cell lines 
[75] 
Polyethylenglycol–
polypropylenesulfidepeptide 
(PEG–PPS-peptide) 
171-601 ABC tri-block 
co-polymer 
HeLa cells [76] 
Continued on next page 
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siRNA Delivery system Diameter 
(nm) 
Type Targeted 
mRNA/tissue/ 
diseases 
Refs. 
Atelocollagen 100-300 Nanoparticles Human 
nonseminomatou 
germ cell tumor 
[77-79] 
Peptide/Protein-based 
    
Acetyl –
GALFLGFLGAAGSTMGAWSQPKKKRKV 
cysteamide 
200 Noncovalent 
nanoparticles 
Various cell types [80] 
Ternary proticles (HSA-Protamine-ODN) 202 Self-assembled 
nanoparticles 
Murine fibroplast [81] 
Cell-Penetrating Peptides 
    
TAT Not 
shown 
Peptide EGFP, CDK98, 
MAP kinase 
[82, 83] 
Penetratin Not 
shown 
Peptide GFP, luciferase, 
SOD, caspase, 
MAP kinase 
[83-85] 
siRNA conjugate 
    
Aptamer-siRNA Not 
shown 
Conjugate Lamini A/C 
siRNA 
[86] 
Antibody-siRNA Not 
shown 
Conjugate Luciferase [87] 
Metal and Semiconductor Nanoparticles 
Quantum dot Not 
shown 
Semiconductor 
nanparticles  
GFP, HeLa cell [88] 
Iron oxide  Not 
shown 
Metal 
nanoparticles 
GFP [89] 
Carbon nanotube Not 
shown 
Nanoparticles Luciferase [90] 
 
The effectiveness of PEI as a siRNA carrier is a result of the electrostatic interaction 
between the positively charged amino groups of PEI and the negatively charged 
phosphate groups in the backbone of siRNA. This interaction leads to the formation 
of small complexes (polyplexes) that are stable enough to transport genetic material 
into cells. PEI-siRNA polyplexes are taken up by cells via endocytosis. Once inside 
the cell, the polyplexes escape from the endocytotic compartment to the cytoplasm 
via the proton sponge mechanism. This release is aided by the augmented influx of 
protons and water due to the presence of PEI, which causes endosomal swelling and 
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the osmotic release of the polyplexes [97,101-104].  Thereafter, the siRNA can be 
incorporated into the RNAi machinery (Figure 2). 
 
 
Figure 2: Proposed mechanism of PEI-mediated siRNA transfer: Due to electrostatic 
interactions, PEI is able to complex with negatively charged siRNAs, leading to a compaction 
and the formation of small complexes which are endocytosed. The"proton sponge effect” 
exhibited by PEI complexes leads to osmotic swelling and ultimately to the disruption of the 
endosomes. Upon their release from the PEI-based complex, intact siRNAs are incorporated 
into the RISC complex and induce RNAi. 
 
PEI offers significantly more protection against nuclease degradation in comparison 
to other polycations, such as poly (L-lysine), possibly due to its higher charge density 
and more efficient complexation ability [105]. The mean size of PEI/siRNA polyplexes 
depends on the N/P ratio, which is defined as the ratio of the number of nitrogens in 
the polycation divided by the number of phosphate groups in the nucleic acid. For 
instance, polyplexes prepared with the commercially available product jetPEI® (linear 
PEI 22 KDa) using a N/P ratio of 10 have a diameter of about 40 nm [106], whereas 
an N/P ratio of 2 leads to a larger polyplexes size (between 120 and 170 nm) [107]. It 
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is noteworthy that the molecular weight of the PEI influences the transfection 
capability of polyplexes. High molecular weight PEI like branched PEI 25 KDa 
polyplexes are highly efficient for transfection [108]. However, branched PEI 25 KDa 
is also characterized by significant cytotoxicity [109-113]. The toxicity can be reduced 
by masking the charges but, at the expense of decreased transfection efficiency 
[110,111,114]. Therefore, much effort has been spent on the modification of PEI in 
order to improve its stability and allow for a high transfection efficacy accompanied 
by a low toxicity [101,115,116]. For example, the amino group modifications of 
branched PEI with several functional moieties were introduced into cells, which 
revealed that succinylation of branched PEI resulted in up to tenfold reduction of 
polymer toxicity in comparison to unmodified branched PEI 25 KDa [115]. Moreover, 
succinylated PEI/siRNA complexes were able to induce remarkable knockdown of 
the targeted luciferase gene at siRNA concentrations as low as 50 nM. Ketalization of 
PEI also leads to a dramatic reduction of the polymer’s toxicity [116]. The modified 
PEI becomes labile at a pH values close to 5.0 and degrades when it reaches the 
endosome (pH 6.5) of the cells, where it can release the nucleic acid. Additionally, 
biodegradable PEI-based nanoparticles containing disulfide bonds offer several 
advantages, including high transfection efficiency and endosomal escape with 
reduced cytotoxicity [101]. 
Polyplexes, however, do not come without limitations.  The most egregious problem 
currently facing this technology is the huge size variation in individual polyplexes. For 
instance, a closer look at the particle size distribution shows that nearly all of the 
produced polyplexes have a particle distribution ranging from 100 nm to more than 
500 nm with a relatively high polydispersity index, which is a numerical 
representation of particle size distribution. Considering that the size and surface 
properties of polyplexes have a great impact on the cellular uptake, internalization, 
and biodistribution of siRNA, such a heterogeneous particle collective is highly 
unfavorable for the transfection process. 
 
Limitation of existing carriers  
In general, the delivery vehicles can affect the resulting biodistribution through 
passive and/or active targeting. Passive targeting occurs as a result of the intrinsic 
physicochemical properties of the carrier. Important aspects that control the 
biodistribution and transfection are the charge and size of the delivery vehicle [117]. 
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While the size and surface properties of the delivery carriers have an influence on the 
circulation and biodistribution of siRNA, they also have an impact at the stage of the 
cellular entry. There are a number of different endocytic pathways to internalize 
macromolecules by cells. These pathways include phagocytosis, macropinocytosis, 
clathrin-mediated endocytosis, caveolin-mediated endocytosis, and clathrin-and 
caveolin-independent endocytosis (Figure 3, bottom) [118,119]. The endocytic 
pathways differ with regard to the size of the endocytic vesicle, the nature of the 
cargo, and the mechanism of vesicle formation.  Each of those pathways is able to 
deliver siRNA into cells. For an efficient RNAi activity, the nucleic acid has to reach 
its cellular target (the cytoplasm) after gaining entry into the cell. This ability strongly 
depends on the internalization pathway and it is highly dependent on the delivery 
system used. It is known that the physicochemical characteristics of particle, as well 
as the actual cell type being targeted, affects cellular uptake [120-123].  In addition, 
the particle's surface properties determine which biomolecules of the extracellular 
environment interact with the particles, which also affects access into cells [124-126]. 
 
 
Figure 3: Top: The various sub-species existing in random siRNA formulation: nanoparticles 
of various composition and size, free siRNA and free carrier. Bottom [taken from 118]: The 
endocytotic pathways into cells can be classified by the mechanism of vesicle formation as 
well as the nature and size of the cargo. 
 
Most of the aforementioned nano-carriers have been used to form nanosized 
complexes with siRNA, which produce random self-assembled aggregates with 
siRNA that are often larger than 100 nm. These systems are generally 
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heterogeneous and poorly defined particle collectives [127-129]. Thus the resulting 
collectives contain particles of various composition and size that are in equilibrium 
with the free polymer and free siRNA (Figure 3 top). 
These polyplexes can be taken up by the cells via different pathways at the same 
time. For example, smaller particles can be taken up via caveolin-mediated 
endocytosis (mean size ~ 60 nm). Larger particles are taken up via clathrin-and 
caveolin-independent endocytosis or clathrin-mediated endocytosis (mean size ~ 90 
and 120 nm respectively) or even via macropinocytosis. The onset of internalization 
will be different according to each particle’s size in this random aggregate. Therefore, 
this heterogeneous collective is taken up by the cell by the various mechanisms as 
illustrated above. Consequently, the polyplexes are unloaded at different places 
inside the cell. This means that the use of random aggregates leads to a decrease in 
the efficacy of siRNA formulations tremendously, since not every sub-species in 
these random preparations is able to elicit the same biological effect. In addition, the 
interpretation of the experimental results is complicated due to the presence of 
different subspecies, since it is not evident which particular subspecies is responsible 
for the overall biological effect.   The biological effect of such a collective will be an 
average of e.g. highly efficient and inactive components coexisting in the siRNA 
formulation. Furthermore, toxic effects may be exhibited by only a fraction of the 
preparation, e.g. the free carrier may appear to be intrinsic properties of the whole 
collective. As well as, it is also difficult to identifying the exact pathway of entry and 
intracellular fate of these heterogeneous nanocomplexes. Consequently, it is 
impossible to establish strategies for the design of new and advanced materials for 
siRNA delivery.  
Therefore, new strategies for the fabrication of small and uniform nanoparticles with a 
defined zeta potential and surface chemistry are necessary to deliver siRNA to 
specific intracellular destinations and elicit a distinctive biological effect.  
 
Gold nanoparticles  
Recently, various metal and semiconductor nanoparticles such as quantum dots, 
carbon nanotubes, iron oxide, and gold nanoparticles have been utilized for the 
development of multifunctional nanoparticles for biomedical applications. In 
particular, gold nanoparticles (AuNPs) have attracted great attention in a variety of 
biomedical fields including DNA mismatch detection [130], biomolecular sensing 
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[131], rapid and sensitive diagnostic assays [132], radiotherapy and imaging 
[133,134] and hyperthermal cancer therapy [135]. This biomedical versatility is mainly 
due to the fact that colloidal gold has well defined chemical, physical, electronic, and 
optical properties with respect to shape and size [136]. Recently, many attempts 
have been made to utilize AuNPs as gene carriers to deliver oligonucleotides or 
plasmid DNA [137-139] and even siRNA into cells [140,141]. For instance, AuNPs 
provide attractive candidates for siRNA delivery because of several advantages, 
including straightforward synthesis, easy surface modification, availability in different 
size range with narrow size distribution, and high biocompatibility with cells or tissues 
[142,143]. Park and co-workers [140] used amine-functionalized AuNPs for 
intracellular delivery of siRNA. The positively charged amine AuNPs formed stable 
polyelectrolyte complexes via electrostatic interactions with negatively charged 
siRNA–polyethylene glycol (PEG) conjugates. This siRNA-(PEG) conjugates had a 
cleavable di-sulfide linkage under the reductive conditions found in the cytosol. The 
presence of PEG chains improved the dispersion stability of the polyelectrolyte 
complexes by protecting them from uncontrollable aggregation. The polyelectrolyte 
complexes of the AuNPs with PEG-conjugated siRNA were internalized to a higher 
extent by human prostate carcinoma cells than the polyelectrolyte complexes 
prepared with siRNA and PEI alone. Furthermore, the green fluorescence protein 
(GFP) expression was suppressed within the cells without eliciting the severe 
cytotoxicity demonstrated in branched PEI. Nagasaki and co-workers conjugated 
thiolated siRNA (SH-siRNA) to AuNPs for cellular delivery [144]. RNA-modified 
particles were coated with poly(ethyleneglycol)-block-poly (2-(N, N -dimethylamino) 
ethyl methacrylate) copolymer to enhance cellular internalization. These delivery 
systems were effective for gene silencing in HuH-7 cells. Recently, Mirkin and co-
workers attached siRNA molecules to the surface of AuNPs via thiol groups [141]. 
The polyvalent siRNA-nanoparticle conjugates showed a six-fold increase in half-life 
in 10% serum and prolonged gene knock down compared to free RNA duplexes. 
Anderson and co-workers conjugated siRNA to poly (ethylene glycol) modified 
AuNPs via a biodegradable disulfide linkage [145]. Further coating of these AuNPs 
with poly (β-amino ester)s facilitated the siRNA delivery in vitro. Without a coating of 
poly (β-amino ester)s, however, siRNA-conjugated AuNPs did not exhibit any 
silencing effect. These approaches demonstrate the general applicability of AuNPs 
as delivery vehicle, but in some of the described cases AuNPs seemed to aggregate 
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after assembly with nucleic acid [137,140], the delivered nucleic acid showed low 
activity inside cells [139], or the efficacy of the nucleic acid relied on an additional 
transfection reagent [138]. 
It is for these reasons that an alternative technique is needed for siRNA delivery 
using AuNPs as a carrier. This technique should be simple, versatile and ease to 
prepare. The technique should not covalently attach the siRNA, thereby avoiding any 
chemical alteration in its structure. An advantage to this requirement is reduced cost; 
unmodified siRNA is much less expensive than modified siRNA. An additional and 
extremely important stipulation is that the particles still be monodisperse after loading 
with siRNA to avoid formation of random aggregates. Such a technique could use a 
Layer-by-Layer (LbL) strategy. We thought that LbL technique would fulfill these 
requirements. This LbL technique would allow us to use monodisperse AuNPs as a 
template for the manufacture of a carrier that remains monodisperse during assembly 
and deliver active siRNA into cells via the deposition of negatively charged siRNA 
and positively charged transfecting agent in alternative order on AuNPs, thereby 
circumventing the limitations of previous systems. 
 
Layer-by-Layer technique 
In the early 1990s, Decher developed a simple, elegant, and extremely powerful 
approach to the formation of controlled architecture multilayer polymer films based 
upon the LbL assembly of oppositely charged polyelectrolytes on a charged solid 
surface [146,147]. These multilayered polyelectrolyte films provide unique and 
attractive thin-film platforms for the controlled release of both small-molecule drugs 
[148-152] and macromolecular therapeutics such as DNA [153-156], and even siRNA 
[157,158].  Caruso and colleagues have pushed the use of LbL assembly technique 
from solid substrate to colloidal particles [159-162]. Colloidal cores of various 
composition (lattices, metal nanoparticles, enzymes, low molecular weight species, 
and cells) and size (nanometer–micrometer–millimeter range) have been coated with 
multilayers of diverse composition and controllable thickness [160-162]. In this 
strategy, depicted in Figure 4, the first added species usually has an opposite charge 
to that of the colloids, thereby adsorbing through electrostatic interactions. An 
overcompensation of charge often results with adsorption of each layer, and at this 
stage the charge on the surface of the particles is reversed. This facilitates the 
alternate deposition of subsequent layers of a wide range of charged components.  
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Figure 4: Schematic illustration of the LbL technique for the surface modification of colloid 
particles. The coatings can be polyelectrolytes (steps 1 and 2), or nanocolloids such as 
inorganic nanoparticles or proteins (steps 1 and 3). The templates can be of different 
composition, size, and shape (latex particles, metal nanorods and nanoparticles, proteins, 
and cells) [adapted from 163]. 
 
Generally, a polyelectrolyte is used to separate layers of the same or different 
materials. These polyelectrolyte interlayers not only act as molecular glue, but they 
can also impart enhanced colloidal stability to the coated particles via electrostatic as 
well as steric contributions. Following deposition of each polymer layer, excess 
polyelectrolyte is removed by centrifugation or filtration, with intermediate water 
washings [163].  
Although there are various experimental parameters that have an impact on LbL 
coating of colloidal particles, the chief issue in transferring the LbL technology from 
planar supports to colloid particles is the effective separation of the remaining free 
(unadsorbed) charged polyelectrolyte species from the colloidal dispersion prior to 
the next deposition cycle. This avoids the formation of polyelectrolyte complexes in 
bulk solution [163]. Coating nanoparticles via the LbL methodology has presented 
tremendous challenges, such as identifying the appropriate parameters for controlling 
particle aggregation and enhancing dispersion stability. These parameters include 
the nature of the polymer, polymer length, concentration, and stiffness. The 
nanoparticles’ curvature, concentration, size, and ionic strength of the adsorption 
solution have a great influence on colloidal stability as well (for review see [164-166]). 
Chapter 1  Introduction and Goals of the Thesis 
- 22 - 
Amongst the colloidal cores utilized for LbL techniques, AuNPs are especially 
attractive for this recombination due to their optical properties. These optical 
properties can be used to investigate the deposition of the coating on their surface. In 
addition, the intensity and aggregation sensitive color of the AuNPs facilitates the 
monitoring of the dispersion stability during all functionalization steps. Lastly, AuNPs 
are biocompatible and gold cores are also easily dissolved by mild methods to form a 
hollow capsule template [163-165]. 
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Goals of the thesis 
Most of the carriers used for siRNA delivery form random self-assembled aggregates 
with siRNA. These aggregates are generally heterogeneous and create poorly 
defined particle collectives. In addition, these particles of different sizes and 
compositions are in equilibrium with free carrier molecules (e.g polymer) and free 
siRNA. Consequently, it is not clear which species is responsible for the overall 
biological effect and the optimization of existing formulations is difficult to achieve. 
Therefore, new and optimized strategies are urgently needed for the highly efficient 
delivery of siRNA to cells.  
In order to get homogeneously distributed nano-carriers with well defined size and 
surface properties for the delivery of siRNA to specific intracellular destinations and 
elicit a distinctive biological effect, we hypothesized that the Layer-by-Layer (LbL) 
strategy using colloidal gold nanoparticles (AuNPs) as a template could allow us to 
manufacture a carrier for siRNA delivery that remains monodisperse during the 
assembly process and delivers active siRNA into cells. In order to fabricate such 
uniform nanoparticles, our approach was to deposit the siRNA as a negatively 
charged polyelectrolyte and a positively charged polyelectrolyte (transfecting agent) 
in alternative order on AuNPs, via the LbL technique as illustrated in (Scheme 1). 
 
 
 Scheme 1: LbL coating of AuNPs 
 
LbL-coated AuNPs are expected to be excellent agents to surmount the described 
limitations due to their high uniformity. In addition, the straightforward tailoring of their 
physicochemical properties makes them a favorable tool to identify parameters for 
highly efficient delivery of siRNA into cells. 
Therefore, the first goal presented in this thesis aimed to the preparation, 
stabilization, and optimization of AuNPs suitable for the coating with siRNA and a 
cationic polyelectrolyte by the LbL technique. First, small AuNPs with a narrow size 
distribution had to be prepared via the citrate reduction method. These nanoparticles 
Polycation 
adsorption 
siRNA 
adsorption 
Polycation 
adsorption 
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then had to be stabilized with a strong ligand to be suitable for the subsequent 
coating steps. Thereafter, it was necessary to identify the optimal pH and ionic 
strength of these nanoparticles for the subsequent coating steps that still garners 
sufficient nanoparticle stability while maintaining optimal wrapping of the 
polyelectrolytes (chapter 2).  
The next goal was to identify the appropriate parameters to successfully coat the 
stabilized AuNPs via the LbL technique, such that the selection of the appropriate 
polyelectrolytes (polycation), concentration of polyelectrolytes, and ionic strength of 
the adsorption solution was achieved. In addition, a very important point was the 
purification of the AuNPs after each coating step before the subsequent deposition 
cycle with the opposite charged polyelectrolyte, which avoids the formation of inter-
polyelectrolyte complexes and aggregation of nanoparticles. Moreover, the toxicity 
and stability of LbL-coated AuNPs in cell culture medium had to be investigated as 
prerequisite for a successful cellular uptake (chapter 3). 
According to the optimized parameters chosen from chapter 3, the intention of 
(chapter 4) was to fabricate LbL-coated AuNPs for siRNA delivery using PEI as a 
polycation. Important parameters to investigate concerning the quality of the coating 
were the physicochemical characteristics and surface properties of the produced 
nanoparticles. Afterwards, the potential of these nanoparticles for use in cellular 
uptake studies had to be evaluated. Therefore, their stability under cell culture 
conditions was investigated as a prerequisite to maintain monodispersity and avoid 
the formation of aggregates. In addition, the functionality of the successfully coated 
AuNPs had to be determined by measuring the gene knockdown and cellular viability 
of nanoparticles in CHO-K1 cells. 
Last but not least, endocytosis is governed by highly sophisticated and well regulated 
principles, and it is known that physicochemical characteristics of the particles 
strongly influence their cellular uptake. Therefore, in order to determine how the size 
and surface properties influence the cellular uptake into the cells, LbL-coated AuNPs 
of different sizes (20, 30, 50, and 80 nm) were produced. Thereafter, the 
physicochemical properties of these LbL-coated AuNPs had to be investigated. In 
addition, the cellular uptake kinetics of different sizes of LbL-coated AuNPs had to be 
determined in different cell lines, since it is known that physicochemical 
characteristics of particles as well as the actual cell type affect cellular uptake. 
Finally, the cell viability of CHO-K1 cells had to be investigated after incubation with 
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different sized LbL-coated AuNPs in order to investigate the suitability of these 
nanoparticles for therapeutic applications (chapter 5). 
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Abstract 
Gold colloids have fascinated scientists for over a century and are now widely used 
in chemistry, biology, physics and medicine. In particular, gold nanoparticles (AuNPs) 
play a vital role in nanoscience and nanotechnology. To date, a number of 
procedures utilizing both physical and chemical methods for the synthesis of AuNPs 
have been reported for the production of AuNPs of different sizes, shapes, and 
surface functionalities related to their practical applications. Due to their unique 
features (tuneable core size, monodispersity, large surface to volume ratio, and easy 
functionalization), AuNPs are also very promising candidates for nucleic acid 
delivery. The goal of this study was to prepare AuNPs that are stable under 
physiological conditions and can be coated with both positively charged polycation 
and negatively charged nucleic acid via Layer-by-Layer (LbL) technology in a 
subsequent step. First, AuNPs were prepared via the citrate reduction method, 
followed by thiol stabilization to obtain stabilized nanoparticles suitable for further 
coating steps. Afterwards, the mercaptoundecanoic acid stabilized AuNPs (MUA-
AuNPs) were investigated at different pH values and ionic strengths to identify the 
optimum conditions for the production of stable monodisperse nanoparticles. MUA-
AuNPs showed a good stability over time with low ionic strength (1-10 mM NaCl), 
and in a wide range of pH values, which allowed further coating at physiological pH. 
In summary, with these optimized conditions the MUA-AuNPs provide a good 
foundation for further coating by polyelectrolytes via LbL technology. 
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1. Introduction 
Gold nanoparticles (AuNPs) play a key role in nanoscience and nanotechnology, with 
applications in fields as diverse as biology, medicine, physics, and chemistry [1]. The 
ability to control the size, shape, and surface functionalization in order to yield certain 
surface properties and manipulate the colloid stability of the AuNPs dispersions 
presents important issues related to practical applications of this technology [2, 3]. 
The synthesis of AuNPs has gained great interest in recent years, due to their unique 
electronic, optical, magnetic, chemical, and biological properties. The first synthesis 
of gold colloids was reported 150 years ago, when Michael Faraday used 
phosphorus to reduce AuCl4- ions [4]. Since then, a plethora of different synthetic 
procedures have been used to obtain AuNPs of different size, shape and dispersion 
media (either aqueous or non aqueous) according to their desired applications [5-7]. 
Aqueous gold nanoparticle dispersions are the most common preparation method, 
especially for biomedical and biological applications. The most popular and simplest 
method is the citrate reduction technique, which was introduced by Turkevitch in 
1951 via reduction of hydrogen tetrachloroaurate (HAuCl4) in boiling sodium citrate 
solution [8]. Subsequently, Frens reported in 1973 that nanosized AuNPs from 15 to 
150 nm can be obtained through an adequate control of the ratio of tri-sodium citrate 
to HAuCl4, with higher ratios yielding smaller particles [9, 10]. The citrate anions have 
dual functions. Initially they act as the reducing agent to reduce Au+3 to Au0, and they 
then act as a stabilizing agent by forming a layer of citrate anions on top of the 
nanoparticle surface, which repels the particles from contacting each other and thus 
preventing the aggregation of the particles [11,12].  Recently, Polte et al. described 
the mechanism of gold nanoparticle formation via the citrate reduction method, where 
four-step nucleation and growth process were proposed [13]. In this mechanism, 
particles are formed through a sequence of reaction steps with the fast initial 
formation of small nuclei of nanoparticles, followed by the coalescence of the nuclei 
into bigger nanoparticles. The third step comprises a slow growth of particles 
sustained by ongoing reduction of gold precursor as well as a further coalescence, 
and finally subsequent fast reduction ending with the complete consumption of the 
precursor species. Throughout these steps the colour of the solution changes from 
pale yellow to dark violet, eventually is ending in a brilliant deep red colour due to the 
formation of nanoparticles. This characteristic red colour of AuNPs is due to their 
strong light absorption in the visible region, caused by the collective oscillation of 
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surface electrons after exposure to light. This phenomenon is called surface plasmon 
resonance (SPR) [14]. The surface plasmon resonance depends mainly on the size 
(e.g AuNPs of 15 nm have a SPR of about 519 nm), shape, composition of particles, 
and the dielectric properties of the surrounding medium [15, 16]. Therefore, it is 
considered one of the most important parameters in the characterization of AuNPs. 
Consequently, particle aggregation, surface modification, and changes in the 
surrounding dielectric medium can be measured as either a peak broadening or peak 
shift in the absorbance spectra [17]. 
The adsorption of citrate anions on the gold surface negatively charges the particles 
and induces enough electrostatic repulsion between individual particles to keep them 
separately dispersed in the synthesis medium [18-21]. However, these molecules are 
weakly bound to the gold surface and form a loose shell of ligands, which is not 
suitable for further modification steps with polyelectrolytic coatings via the Layer-by-
Layer (LbL) technique. It is proposed that the polycation/polyanion electrostatic 
attraction in multilayers is stronger than the one between the positive polyelectrolyte 
and the surface of the AuNPs. This would cause dewrapping of the positive polymer, 
resulting in a solution of bare gold particles and free polyelectrolyte [22]. This effect 
may be overcome by covalently immobilizing the surface charge on the nanoparticles 
by the use of a suitable molecule, instead of the chemisorbed surface charge from 
layers of citrate ions. Therefore, the use of ligands stronger than citrate was a major 
improvement for the synthesis and handling of AuNPs [15]. Thiols are the most 
important type of stabilizing agents for AuNPs of any size. This is because the thiol 
group is covalently attached to the nanoparticle surface, which forms strong covalent 
Au-S bonds as shown in Figure 1 [15]. This stabilization of AuNPs with thiol is an 
electrostatic stabilization.  
  
 
Figure 1: Thiol stabilization of AuNPs 
  
    Citrate-stabilized AuNPs Thiol-stabilized AuNPs 
Thiol exchange 
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There are two basic modes to stabilize AuNPs [23]. The one already described is the 
electrostatic stabilization, based on the electrical double layer repulsion between the 
particles. The other is steric stabilization, achieved by the coordination of sterically 
bulky organic molecules such as polymers that act as protective shields on the 
metallic surface. The main differences between steric and electrostatic stabilization 
are summarized in (Table 1). An electrostatic-stabilized dispersion will not be stable 
and will coagulate on the addition of high concentrations of electrolytes. In contrast, 
with steric stabilization the dimensions of polymer chains (the steric hindrance of 
polymer chain) display no such dramatic sensitivity to polyelectrolytes; therefore 
sterically stabilized dispersions are relatively insensitive to the presence of 
electrolytes.  
 
Table 1: Comparison between steric and electrostatic stabilization   
Item Steric stabilization Electrostatic stabilization 
Stability  Independent of the ionic 
strength and pH 
Stabilization depends on the ionic 
strength and pH of the solvent 
Electrolyte Insensitive to electrolyte Coagulate on addition of electrolyte 
Media  Effective in both aqueous  
and non aqueous dispersion 
Effective mainly in aqueous 
dispersion 
Colloid  Effective at high and low  
colloid concentration 
ineffective at high colloid 
concentration 
Aggregation Reversible flocculation possible Coagulation usually irreversible 
 
In addition, electrostatic stabilization is less effective in non aqueous dispersion 
media than it is in aqueous media. This is primarily due to the low relative dielectric 
constant of most non aqueous media. Moreover, the coagulation of electrostatic-
stabilized particles induced by the addition of electrolyte is usually irreversible. In 
contrast, the flocculation of sterically stabilized dispersions can usually be reversed 
spontaneously.  
Although steric stabilization has several advantages over electrostatic stabilization, 
we will focus on electrostatic stabilization. This is due to the fact that the charged 
surface of the AuNPs is necessary for the further deposition of the charged polymers 
(polyelectrolytes). This means that for the coating of AuNPs via the LbL technique, 
an electrostatic interaction between positively and negatively charged 
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polyelectrolytes is required for proper layer buildup. Therefore, we will focus on the 
factors that influence electrostatic stabilization of colloidal nanoparticles.  
Most colloids will acquire a surface electric charge when dispersed in a polar medium 
such as water. This electric charge can be generated through the ionization of a 
surface functional group on the colloid, ion adsorption, or by the partial and unequal 
ion dissolution of the colloidal material [24]. An important consequence of the charge 
on the particle surface is that an electrical double layer around the colloid is produced 
in polar solutions. The double layer consists of two regions of charge as shown in 
(Figure 2).  
 
 
Figure 2: A schematic representation of the electrical double layer and Zeta potential of a 
charged particle in a polar environment [25] 
 
Counterions in the region closest to the charged wall surface are strongly bound to 
the surface. This immobile layer is called the Stern or Helmholtz layer. The region 
adjacent to the Stern layer is called the diffuse layer and contains loosely and thus 
relatively mobile ions. Within the diffuse layer there is a notional boundary inside 
which the ions and particles form a stable entity. This boundary is called the surface 
of hydrodynamic shear, or slipping plane. The potential that exists at this boundary is 
known as the zeta potential (ξ-potential), which is very important parameter in the 
theory of interaction of colloidal particles [24]. The thickness of the electric double 
layer is known as the Debye-Huckel length K-1. It is reciprocally proportional to the 
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square root of the ion concentration [24].  The electric potential associated with the 
double layer decreases as a reciprocal function of the distance from the particle and 
approaches zero as the counterions gradually reduce the effect of the field created 
by the surface. When two particles approach each other, the overlap of the 
counterions in the diffuse layer gives rise to Coulombic repulsion force between the 
particles and repulsion potential. With respect to particle-particle interactions, which 
determine colloid stability, the most widely accepted quantitative model (described by 
Derjaguin and Landau, and independently by Verwey and Overbeek) is known as 
(DLVO) theory [26]. This theory states that the total free energy of interaction is 
composed of two terms, Van der Waals and electrostatic interactions, as shown in 
equation 1.   
VT = V A + V R   (1) 
In this equation, VT is the total interaction energy, VA is the attractive potential 
energy, and VR is the repulsive potential energy. 
Van der Waals forces (VA) between two identical particles are generally attractive. 
Electrostatic forces (VR) due to the overlapping of electrical double layers are 
generally repulsive. Figure 3 illustrates the potential energy between two particles as 
a function of interparticle distance. In brief, if the Coulombic repulsion force is high 
enough to counteract the Van der Waals force, then the electrostatic repulsion will 
prevent the particles from aggregation [26]. 
The combination of the two interactions typically generates an energy barrier. Hence, 
the height of the energy barrier determines whether a colloid will be stable or 
undergo coagulation. Factors such as the surface potential and the electrolyte 
concentration (ionic strength) influence the height of the energy barrier and can be 
used to control colloid stability. 
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Figure 3: The potential energy of interaction as described by DLVO theory [27] 
 
The higher the potential at the surface of a particle, the larger the electrostatic 
repulsion between the particles will be. The lower the concentration of indifferent 
electrolyte, the larger the distance from the surface at which repulsion is significant 
(e.g., the Debye–Huckel length is larger) (see Figure 4A). Therefore, both a higher 
potential at the particle surface and a lower concentration of inert electrolyte increase 
the height of the energy barrier and consequently the colloidal stability.  However, 
increasing the ionic strength decreases the Debye-Huckel length [28], and this leads 
to a decreasing of the average distance of closest approach between particles 
(Figure 4). As this distance decreases, the repulsion due to double layer overlap 
declines. 
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Figure 4: The relation between electrolyte concentration and double layer thickness (Debye-
Huckel length) [picture B taken from 29] 
 
Therefore, the degree of electrostatic screening (Debye-Huckel length) between two 
point charges in aqueous dispersion is directly proportional to the added salt 
concentration (ionic strength), as shown in equation 2. 
clk bpi8=    (2) 
Where k is the inverse Debye-Huckel screening length (nm-1), lb is the Bjerrum length 
(for water it is approximately 0.7 nm), and c is the ionic strength of a monovalent salt 
(mol dm-3).  
In summary, in order to obtain AuNPs suitable for coating with polyelectrolyte by the 
LbL strategy, the nanoparticles should first be stabilized with a strong ligand. In a 
next step important parameters that influence the stability of electrostatic stabilized 
nanoparticles should be addressed to achieve a high colloidal stability for the AuNPs. 
Therefore, the objective of this chapter was to describe the preparation and 
stabilization of AuNPs using 11-mercaptoundecanoic acid (11-MUA). Subsequently, 
the stabilized particles were optimized at different pH values and ionic strength to 
select the optimum conditions to produce stable monodisperse particles suitable for 
the subsequent coating steps with polyelectrolytes by the LbL technique. 
 
  
 
 
A B 
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2. Experimental 
2.1. Materials  
Hydrogen tetrachloroaurate tri-hydrate (HAuCl4·3H2O), and 11-Mercaptoundecanoic 
acid (11-MUA) were purchased from Sigma-Aldrich Chemical Company (Steinheim, 
Germany). Tri-sodium citrate dihydrate, sodium chloride, sodium hydroxide, nitric 
acid, hydrochloric acid, and absolute ethanol were purchased from Merck 
(Darmstadt, Germany). All glassware was thoroughly washed with freshly prepared 
aqua regia (HCl: HNO3 = 3:1) [Caution! Aqua regia is a strong acid], extensively 
rinsed with Millipore water several times and oven-dried at 150 °C for 2-3 h before 
use. All solutions were filtered through 0.22 µm membrane filter (Corning 
Incorporated, Corning NY 14832, Germany) before use. 
 
2.2. Preparation of gold nanoparticles 
AuNPs were prepared as previously described with slight modifications, using the 
standard reduction of tetrachloroauric(III) acid with tri-sodium citrate [9, 30]. Citrate 
gold nanoparticles (citrate-AuNPs) of approximately 18 nm in diameter were obtained 
using the following conditions: 1 ml of 1% HAuCl4·3H2O solution was mixed with 100 
ml of Millipore water in a 250 ml round flask and heated under reflux until boiling. 2.5 
ml of a 1% tri-sodium citrate solution was added under vigorous stirring. Boiling was 
continued for 10 min, and then the reaction vessel was removed from the heating 
element. Stirring was continued for an additional 15 min. Larger aggregates were 
removed by centrifugation at 2.450 xg. The produced nanoparticles were 
characterized by UV-vis spectroscopy, size and zeta potential measurements using 
photon correlation spectroscopy. 
 
2.3. Stabilization of the produced citrate gold nanoparticles 
The pH of citrate-AuNPs was adjusted to 11 with 1N NaOH, followed by addition of 
differing amounts of 11-MUA which was sonicated in ethanol (to ensure complete 
dissolution) at a final concentration of 0.1 and 0.2 mg/ml. The gold sols were 
incubated under continuous stirring at room temperature overnight to allow sufficient 
exchange of citrate anions on the particle surface. The stabilized particles were 
purified two times at 15.700 xg for 10 minutes for removal of excess 11-MUA, and 
resuspended in Millipore water [31].  
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2.4 Characterization of the gold nanoparticles 
2.4.1. UV-visible spectroscopy of AuNPs 
UV-vis absorbance spectra of the AuNPs were recorded using an Uvikon 941 
spectrophotometer (Kontron Instruments GmbH). 
2.4.2. Size and zeta potential measurements by dynamic light scattering (DLS) 
For the determination of size and ξ-potential, 0.5 ml of AuNPs was diluted with 1.5 ml 
Millipore water. The samples were adjusted to 25 0C and laser light scattering 
analysis was performed with an incident laser beam of 633 nm at a scattering angle 
of 900 using the Malvern ZetaSizer 3000 HSA (Malvern Instruments GmbH). The 
sampling time was set automatically. Three measurements each with 10 sub-runs 
were performed for each sample. The intensity of the autocorrelation function of the 
sample was deconvolved with the non-negatively constrained least squares (NNLS) 
algorithm because it provides a high resolution analysis and the quality of the fitting 
passed in all measurements. The ξ-potential measurements were performed in the 
standard capillary electrophoresis cell of the ZetaSizer 3000 HSA (Malvern 
Instruments GmbH), measuring the electrophoretic mobility at 25 0C.  As described 
elsewhere, these mobilities (u) were converted to the ξ-potential using the 
Smoluchowski relation ξ = uη/ε, where η and ε are the viscosity and permittivity of the 
solution respectively [32]. 
2.4.3. TEM image of the gold nanoparticles 
Transmission electron micrographs (TEM) of AuNPs were taken on a Philips CM12 
microscope (FEI, Eindhoven, The Netherlands). Samples were prepared by 
depositing the colloidal gold solution onto a carbon-coated copper grid and then air-
dried before analysis. Several micrographs of the sample were taken. For statistical 
evaluation, the diameter of 500 AuNPs cores was measured using Image J (NIH 
Image). 
2.4.4. Determination of gold nanoparticles concentration by ICP-OES 
The concentration, and consequently the number of AuNPs per volume after 
synthesis, was determined by using inductively coupled plasma-optical emission 
spectroscopy (ICP-OES). 500 µl of a sample containing AuNPs was mixed with 200 
µl of freshly prepared aqua regia [Caution! Aqua regia is a strong acid] and diluted to 
5 ml with Millipore water. The Au3+ content of the solution was determined by ICP-
OES analysis on a JY-70 PLUS (Jobin Yvon Instruments S.A.). The plasma flow was 
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16 L/min argon. All standards were made with gold (III) chloride at a concentration of 
1, 10, 100 and 1000 ppm. The measured concentration of Au3+ was divided by the 
number of gold atoms per particle to obtain the concentration of AuNPs in solution 
[33].  
 
2.5. Stability study of MUA-AuNPs 
In order to determine the stability of different amounts of 11-MUA capped AuNPs to 
choose the optimum concentration for stabilization, a time scale experiment was 
performed and the stability of the colloidal dispersions was monitored by size 
determination, ξ-potential measurement and the changes in the UV-vis spectra of 
nanoparticle dispersions. In addition, the effect of different pH on the stability of the 
nanoparticles was studied by UV-vis spectroscopy, size determination and ξ-potential 
measurement. Finally, to study the influence of different ionic strength on the stability 
of MUA capped AuNPs, the purified particles were resuspended in different 
concentration of NaCl (1, 2, 5, 10, and 30 mM) and particle size distributions as well 
as ξ-potential and UV-vis absorbance were determined.  
 
3. Results and discussion 
3.1. Preparation, stabilization and characterization of gold nanoparticles 
Small and monodisperse AuNPs were obtained using the citrate reduction method 
and a citrate:HAuCl4 ratio of 2.5:1. The produced particles were mainly spherical and 
monodisperse as shown by the TEM (Figure 8). The hydrodynamic diameter of 
citrate gold nanoparticles (citrate-AuNPs) was 18.2 ± 0.5 nm with low polydispersity 
index (0.182) as determined by dynamic light scattering. The AuNPs had a negative 
surface charge of citrate anions as investigated by ξ-potential. Because of the 
negative charge formed due to the adsorption of citrate anions which were weakly 
bound to the gold surface, it made them unsuitable for further coating steps as 
described earlier. A stronger stabilizing agent is required to achieve LbL coating. 11-
MUA is one of the thiol compounds which form a strong covalent bond with the gold 
surface. Hence, citrate-AuNPs were further stabilized by 11-MUA.  First, the pH of 
citrate-AuNPs was elevated to 11. This high basicity is important in reinforcing 
eletrostatic stabilization, because at a high pH the carboxyl groups of 11-MUA are 
deprotonated and stabilize the particle dispersion through electrostatic repulsion [31, 
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34]. Two different concentrations of 11-MUA were added to the colloidal gold in order 
to determine the optimum concentration required for nanoparticle stabilization. The 
strong surface-plasmon band absorbance of AuNPs in the visible spectrum was used 
to characterize the AuNPs before and after coating (Figure 5). MUA stabilized gold 
nanoparticles (MUA-AuNPs) exhibited a surface plasmon resonance band at 522 nm, 
which is slightly broadened and red shifted compared to that of citrate-AuNPs, which 
had UV absorbance at 519 nm. The red shift in the surface plasmon band is 
attributed to the change in the dielectric constant of the medium surrounding the 
AuNPs [35-37], as well as the electron-withdrawing properties of the SH group [38]. 
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Figure 5: UV-vis spectra of citrate-AuNPs and different concentrations of 11-MUA stabilized 
AuNPs  
 
In order to determine the optimal parameters for the stability of MUA-AuNPs, the 
size, polydispersity index, surface charge, and the change in surface plasmon 
resonance were determined at different time intervals. These time intervals were 
chosen  since the literature states that the suitable time for stabilization of AuNPs 
with thiols may take anywhere between 20 hrs [31] to three days [22]. Figure 6 shows 
the effect of different concentrations of 11-MUA on the size and polydispersity index 
of the AuNPs compared to citrate-AuNPs. The size of citrate-AuNPs was 18.2 ± 0.5 
nm as determined by dynamic light scattering, while this size increased to 22.0 ± 0.4 
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and 29.0 ± 1.2 nm after stabilization with 0.1 and 0.2 mg/ml 11-MUA, respectively. 
The polydispersity index of 0.2 mg/ml MUA was higher than those of 0.1mg/ml MUA, 
which could be due to the presence of higher amount of free thiols. 
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Figure 6: The hydrodynamic diameter of citrate (░), 0.1mg/ml MUA (▓), 0.2mg/ml MUA (█) 
and the polydispersity index of citrate (●), 0.1mg/ml MUA (▲) and 0.2mg/ml MUA (■) AuNPs 
were measured at different time points 
 
The surface charge plays an important role in the stability of the nanoparticles, and 
the magnitude of the zeta potential gives an indication of the potential stability of the 
colloidal system. Therefore, the ξ-potential of citrate and MUA-AuNPs was also 
measured as a function of time (Figure 7). The ξ-potential of citrate-AuNPs was -35.5 
± 3.5 mV, while it became more negative after stabilization with 11-MUA to be about -
59.5 ± 0.7 and -64.3± 6.6 mV for 0.1 and 0.2 mg/ml, respectively. This increase in the 
ξ-potential could be due to the replacement of citrate anions with thiol. Furthermore, 
there was no significant difference between the two concentrations of MUA in the ξ-
potential over 4 days, indicating satisfactory stability of the produced nanparticles. 
Additionally, the surface plasmon resonance of stabilized particles did not change 
over time, again confirming the stability of the particles (data not shown), since any 
increase in the size of AuNPs would be accompanied by a red shift in the surface 
plasmon resonance [39]. 
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Figure 7: The zeta potential of citrate (░), 0.1mg/ml MUA (▓), and 0.2mg/ml MUA (█) AuNPs 
were determined at different time points 
 
It was found from the above results that there were no significant differences 
between 0.1 and 0.2 mg/ml MUA stabilized gold nanoparticles in the ξ-potential and 
surface plasmon resonance, and both concentrations showed good stability over the 
time. However, 0.1 mg/ml MUA-AuNPs showed smaller size and a lower 
polydispersity index than 0.2 mg/ml MUA-AuNPs. Therefore, 0.1 mg/ml MUA was 
chosen as optimum concentration for stabilization of AuNPs. 
To further characterize the morphology and to verify the size of the prepared 
nanoparticles in comparison with the hydrodynamic diameter, imaging of the AuNPs 
by transmission electron microscopy (TEM) was applied. Both the citrate and MUA-
AuNPs were spherical and highly monodisperse (Figure 8). The average core 
diameters of the AuNPs were 18.3 ± 1.4 nm as calculated using Image J software 
counting of 500 AuNPs cores. In order to determine the concentration of AuNPs and 
to make a batch to batch characterization, the gold content of the nanoparticles was 
analyzed by ICP-OES. 
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Figure 8: Transmission electron micrographs of citarte-AuNPs and MUA-AuNPs. The size is 
18.3 ± 1.4 nm calculated using Image J. The large crystal in the left image is from an excess 
of sodium citrate  
 
The measured concentration of Au3+ was divided by the number of gold atoms per 
particle to obtain the concentration of AuNPs in solution. The number of gold atoms 
per particle was then calculated using the particle diameter, the density of bulk gold, 
and the molecular weight of gold. The value was determined to be 18.9 x 104 atoms 
per particle. Additionally, the number of nanoparticles per ml was calculated based 
on the ICP-OES measurement and the TEM images, and found to be approximately 
1.31 x 1012 particles/ ml [40]. 
 
3.2. Stability of MUA-AuNPs in different pH 
It is important to study the stability of MUA-AuNPs in different pH values in order to 
control the environmental conditions around the particles and to select the optimum 
pH suitable for coating with polyelectrolytes via the LbL technique. A pH of 7 would 
be favored, since it is very near normal physiological pH; all cell culture systems of 
mammalian cells have this pH. 
Decreasing the pH of the stabilized particles from 11 to 5 was done by the addition of 
HCl to the colloidal gold and the absorption spectrum of the nanoparticles was 
monitored. After the gradual pH decrease 11 to 5, there was no change in the 
surface plasmon resonance (data not shown). More interestingly, the surface 
plasmon resonance did not change even after re-elevation of the pH to 11 again 
using NaOH, which strongly agrees with the results reported by other authors who 
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studied the stability of different thiol capped AuNPs in different pH environments [41-
43]. At pH values below the pKa of 11-MUA (pKa 4.6) the color of the nanoparticles 
changed rapidly from red to blue, indicating an aggregation of the particles. These 
aggregations are generated from the intermolecular hydrogen bonds created from 
the protonation of 11-MUA [32, 44]. In further experiments, the stability of MUA-
AuNPs was studied at pHs of 7 and 11. The hydrodynamic diameter and 
polydispersity index, as well as ξ-potential of particles, was determined at different 
time scales. There was no difference in the size and polyindex of the stabilized 
particles at different pH values even after 3 days, which is shown in Figure 9.  
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Figure 9: The hydrodynamic diameter of citrate (░), 0.1mg/ml MUA pH7 (▓), 0.1mg/ml MUA 
pH11 (█) and the polydispersity index of citrate (●), 0.1mg/ml MUA pH7 (▲) and 0.1mg/ml 
MUA pH11 (■) AuNPs were measured at different time points 
 
Figure 10 shows the ξ-potential of MUA-AuNPs at pH 7 and 11 over 3 days, also 
here there was no significant difference in the ξ-potential of stabilized particles at 
different pH, it was -59.5 ± 0.7 and -55.6 ± 2.8 mV at pH 11 and 7, respectively. 
Furthermore, these particles were still stable after 3 days, with only a slight decrease 
in the ξ-potential (the ξ-potential did not decrease than about -50 mV). As known 
from the literature, aggregation is very unlikely for charged particles with optimum 
zeta potentials (ξ > 30 mV) because of the electrostatic repulsion forces between 
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similarly charged particles [45]. Consequently, the charged particles stay dispersed, 
since the double layer repulsion caused by the charges can successfully counteract 
the attractive Van der Waal forces between two identical gold spheres [46]. 
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Figure 10: The zeta potential of citrate (░), 0.1mg/ml MUA pH7 (▓), and 0.1mg/ml MUA 
pH11 (█) AuNPs were measured at different time scales 
 
In summary, the stabilized particles did not show any significant difference in their 
hydrodynamic diameter, polydispersity index or ξ-potential at different pH values. 
Therefore, a pH of 7 was selected as the optimum pH for further experimentation, 
since the physiological pH (pH 7) is more favorable for nucleic acid assembly via LbL 
technology and it is important for internalization of the particles within the cell. 
 
3.3. Effect of different ionic strength on MUA-AuNPs 
Ionic strength plays an important role in the stability of a colloidal system, especially 
those stabilized via electrostatic interaction. Moreover, it is considered one of the 
most important parameters that influence the wrapping of the polymer around AuNPs 
in LbL technology, due to its ability to reduce the stiffness of the polymer. Therefore, 
the stability of the particles in different ionic strength was determined by monitoring 
the change in the surface plasmon resonance, particle size distribution, and zeta 
potential. Both the hydrodynamic diameter and polydispersity index serve as very 
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important indicators for the quality and stability of the nanoparticles. Figure 11 shows 
that the hydrodynamic diameter of the purified MUA-AuNPs in water, 1, and 2 mM 
NaCl did not differ from the crude MUA-particles. It was approximately 21 nm with the 
polydispersity index 0.25 (satisfactorily low), while the size and polyindex slightly 
increased with 5 and 10 mM NaCl to about 24 nm and 0.37. With 30 mM NaCl the 
size reached to 35.8 nm and the polydispersity index became 0.518, which indicates 
the beginning of particle instability and aggregation. This is attributed to a decrease 
in the Debye length between the particles because of the increased ionic strength. 
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Figure 11: The hydrodynamic diameter (white columns) and the polydispersity index 
(rhombs) of MUA-AuNPs at different ionic strength of NaCl 
 
Table 2 represents the λmax and ξ-potential at different ionic strength. The purified 
particles in 1 and 2 mM NaCl had the same λmax as the purified particles in water (522 
nm). This could be attributed to the fact that the very low ionic strength did not have 
much influence on the surface plasmon resonance. While at higher ionic strength, 
little increase in the maximum absorbance was observed, which shifted to 524 nm in 
case of 5mM NaCl and then 525 and 526 nm at 10 and 30 mM NaCl, respectively. It 
is known from the literature that the ionic strength has an influence in the optical 
properties of AuNPs, where ionic strength should cause the nanoparticle’s surface 
plasmon color change. This phenomenon is more pronounced at high ionic strength 
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and in divalent cations rather than monovalent ones [47]. At ionic strength higher 
than 30 mM NaCl the color of the nanoparticles rapidly changed from red to blue, 
which indicates the aggregation of the nanoparticles. This aggregation is generated 
from the reduction of electrostatic repulsion between surface-charged nanoparticles 
by the added ions and the decreasing distance between the particles, thereby 
favoring the interactions felt by the Van der Waals forces [16, 48]. It is also clear from 
this table that there was no significant difference in the ξ-potential at lower ionic 
strength, which is also attributed to very low salt concentration not altering the ξ-
potential. Only slight reduction was observed from 5 to 30 mM NaCl. 
 
Table 2: Effect of ionic strength on the surface plasmon resonance and zeta potential of 
purified MUA-AuNPs  
Ionic strength λmax ξ- Potential 
0 mM 522 nm -53.6 ± 2.7 mV 
1 mM 522 nm -60.2 ± 2.3 mV 
2 mM 522 nm -56.2 ± 1.3 mV 
5 mM 524 nm -61.1 ± 1.5 mV 
10 mM 525 nm -59.2 ± 1.4 mV 
30 mM 526 nm -53.0 ± 1.0 mV 
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4. Summary and conclusion 
Monodisperse and uniform AuNPs of 18.2 ± 0.5 nm were prepared in aqueous 
solution using the citrate reduction method according to [9, 30] with slight 
modification. The stabilization of AuNPs with 0.1 mg/ml 11-MUA was found to be 
suitable for subsequent coating via LbL technique. After stabilization, the size of the 
stabilized particles only slightly increased compared to citrate stabilized particles, and 
also had a narrow particle size distribution and low polydispersity index. In addition, 
the zeta potential became more negative, possibly due to the replacement of citrate 
anions with thiol. Furthermore, the stabilized particles showed a good stabilization 
over time and in a wide range of pH values, which allows further coating at 
physiological pH.  Additionally, MUA-AuNPs had good stability in low ionic strength 
(1-10 mM NaCl) which is important for the flexibility of the polymer chain, which 
reduces the chain stiffness and allows for the complete wrapping of the polymer 
around nanoparticles. However, at higher ionic strength the particles aggregated. In 
summary, the MUA-AuNPs presented here provide a valuable tool for further coating 
by polyelectrolytes via LbL technology. 
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Abstract 
The design of advanced nanostructured materials is of great interest, with broad 
applications in the biomedical field. Among the available techniques, the Layer-by-
Layer (LbL) assembly method has attracted extensive attention. LbL assembly is a 
simple, versatile, and comparatively inexpensive approach with the capability of 
achieving high loads with numerous types of biomolecules. Gold nanoparticles 
(AuNPs) are the most commonly used nanocore for the LbL deposition of 
polyelectrolytes and are considered a good model for understanding the parameters 
controlling polymer multilayer formation on nanoparticles. In order to coat AuNPs with 
polyelectrolytes via the LbL technique for nucleic acid delivery, appropriate 
parameters had to be identified. First, the suitability of the polycations protamine 
sulfate (~ 5 KDa) and poly(ethylene imine) (PEI) 25 KDa for LbL assembly for nucleic 
acid delivery using 21 base pair DNA as a model was investigated. Additionally, other 
important parameters (such as polyelectrolyte concentration, ionic strength, and the 
purity of the nanoparticles after a subsequent coating step) were also determined. 
Having optimized the conditions, AuNPs were successfully coated with 1 mg/ml PEI 
at 1 mM NaCl and 1.5 µM 21 bp DNA at 10 mM NaCl in alternative order via the LbL 
approach. Moreover, the LbL-coated AuNPs showed good stability in a culture 
medium containing serum and were taken up by CHO-K1 cells. Thus, nucleic acid 
delivery can be achieved via LbL technology using these optimized parameters. 
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1. Introduction 
Controlling the surface properties of colloidal materials is a major research interest in 
the field of nanomedicine for biomedical applications, such as the delivery of small 
drug molecules or large biomolecules, like proteins and nucleic acids, into cells. 
There are several ways to modify the surface of a colloidal particle, including the 
attachment of small ligands or polymers via either covalent or non-covalent binding 
[1]. In particular, the coating of colloidal particles with polymers is a favorable method 
to modify surface properties, with the polymer type determining the final surface 
characteristics of the particles. Among polymers, polyelectrolytes (charged polymers) 
are frequently used to modify flat surfaces [2-5] and colloids (curved surfaces) [6, 7]. 
Polyelectrolytes have an advantage over uncharged polymers, since they can be 
self-assembled onto the surface and contain certain charged functional groups that 
may be directly attached by electrostatic interaction onto the particles. A technique 
exploiting this mechanism is the Layer-by-Layer (LbL) deposition of polyelectrolytes 
on colloidal surfaces, which enables the total polymer thickness to be determined by 
the number of layers deposited [4]. This alleviates the need for chemical routes to 
modify particles [8]. 
The adsorption of polyelectrolytes onto oppositely charged spherical particles 
depends on various parameters, including the polyelectrolyte chain length, type, and 
concentration, particle diameter and concentration, and the ionic strength of the 
adsorption solution [9]. The main problems in transferring the LbL technique from 
macroscopic flat substrates to the surface of colloidal particles lies in the separation 
of the coated colloids from free, excess polyelectrolyte prior to the next deposition 
cycle. In addition, flocculation instead of layer growth is often induced by the added 
polyelectrolyte, as shown in Figure 1a. In this case, the two ends of the long chain 
polyelectrolyte may adsorb onto different colloidal particles and then draw them 
together, leading to bridging flocculation. To prevent these undesirable effects, the 
initial colloidal substrate and each of the employed polyelectrolyte species has to be 
sufficiently charged. Moreover, it has to be ensured that the particles are added to 
the polyelectrolyte solution and not vice versa, and that the amount of the adsorbing 
polyelectrolyte is large enough to provide a complete surface coverage. If this 
requirement is not met, incomplete layer growth and aggregation arising from the 
coexistence of particles having different charge density occurs [10]. Recently, Decher 
et al. investigated the appropriate parameters required to prevent bridging 
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flocculation during polyelectrolyte adsorption and enhance the stability of the colloidal 
dispersion. They used gold nanoparticles (AuNPs) as a core and poly(allylamine 
hydrochloride) (PAH) and poly(styrene sulfonate) (PSS) as the polycation and 
polyanion, respectively. They concluded that by controlling the experimental 
parameters such as nanoparticle concentration, polymer charge density, 
concentration, and length and the concentration of added salt, AuNPs can be coated 
with up to 10 layers of polyelectrolytes (five pairs of PAH/PSS layers). Under these 
selected conditions the recovery yield of individual particles was higher than 90% per 
adsorption cycle accompanied only by very small amounts of oligomeric aggregates 
(for review see [11]).  
 
 
 Figure 1: Simple representations of nanoparticles being aggregated by bridging flocculation 
(a) and being individually wrapped by polymer chains (b) [10] 
 
The ionic strength plays an important role in the colloidal stability of nanoparticles 
and is considered one of the most important parameters in LbL technology. The 
choice of the ionic strength during LbL build-up is made with consideration to the 
Debye-Huckel screening length (nm-1) (see [chapter 2]). The Debye-Huckel length is 
given by k = c0.5/0.304, where c is the ionic strength of monovalent salt solution [12]. 
It is known that the ionic strength required to reduce the chain stiffness of the 
polymer in order to coat particles with polyelectrolytes of a given length increases 
with decreasing particle size [13, 14]. In addition, shorter polymer chains need higher 
salt concentrations to be flexible enough to wrap around the colloid. However, a high 
ionic strength may cause aggregation of the AuNPs, whereas high molecular weight 
polymers induce flocculation through bridging [15]. Therefore, a low molecular weight 
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polymer and a low salt concentration are desired to successfully coat small 
nanoparticles. 
Although the fabrication of multilayered polyelectrolyte films is a well-established 
method for nucleic acid delivery [16-20], after a comprehensive literature search we 
determined that the delivery of nucleic acid via LbL technique using AuNPs as a 
template has not been performed. This is due to the fact that biomacromolecules 
such as DNA and short interfering RNA (siRNA) are stiff and rodlike molecules that 
do not easily wrap around of high surface curvature small nanoparticles [21]. 
Therefore, in order to coat AuNPs with polyelectrolyte for nucleic acid delivery via the 
LbL technique, it is important to choose an appropriate combination of polycation and 
nucleic acid. In addition, identifying the suitable parameters required for successful 
assembly, such as polyelectrolyte concentration and ionic strength of the adsorption 
medium, will be a major issue.  
Both nature and polymer chemistry provide an enormous wealth of materials 
potentially suitable as polycations for the coating. Unfortunately, very few synthetic 
couples have been studied so far with regard to their properties concerning LbL 
formation [22]. A plethora of materials have been used as polycations for the LbL 
assembly process such as poly(diallyldimethylammonium chloride) (PDDA), 
polyallylamine hydrochloride (PAH), poly-L-lysine (PLL), poly-L-arginine (PLA), 
poly(ethylene imine) (PEI), and protamine [10, 22]. In particular, PEI and protamine 
have additionally been shown to form complexes with nucleic acids that are delivered 
into cells [23, 24]. Protamine is a natural polymer and a highly basic peptide which is 
constituted of 75% arginine. It is available in large quantities from fish sperm. One of 
its biological functions is to ensure compaction of DNA [25, 26]. Regarding the 
possible use of LbL multilayers containing protamine, it is interesting to note that 
protamine slows down the release of insulin when insulin/protamine complexes are 
used [27]. Both these features of protamine are based on polyelectrolyte complex 
formation. Hence, protamine should be a suitable candidate for LbL formation with a 
wide range of anionic biopolymers [28, 29]. On the other hand, PEI has already been 
used for nucleic acid delivery via LbL technique using flat surfaces [30]. Although PEI 
is a synthetic polymer and has pronounced cytotoxicity [31], it is considered the gold 
standard for nucleic acid delivery, due to its high transfection efficiency and 
endosomal escape through the proposed proton sponge effect [32-34]. Therefore, 
the goal of this chapter was to investigate if mercaptoundecanoic acid stabilized gold 
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nanoparticles (MUA-AuNPs) [from chapter 2] can be coated with either protamine or 
PEI as a polycation and DNA as a polyanion via the LbL technique.  
First, the suitability of the polycations protamine and PEI for LbL assembly for nucleic 
acid delivery using 21 base pair DNA as a model was investigated. In addition, the 
appropriate parameters of polyelectrolyte required for assembly, such as the 
concentration of polyelectrolyte, the ionic strength required to achieve complete 
wrapping of polyelectrolyte around nanoparticles, and purification of AuNPs after 
subsequent coating, were determined. The toxicity of the produced LbL-coated 
nanoparticles was also measured in a cell culture model. Moreover, the stability of 
the resulting LbL nanoparticles after the whole fabrication was determined in a 
culture medium to examine if these nanoparticles are still monodispersed or 
aggregated after exposure to culture medium. Subsequently, the cellular uptake of 
the produced nanoparticles was investigated.   
 
2. Experimental 
2.1. Materials  
Hydrogen tetrachloroaurate tri-hydrate (HAuCl4·3H2O), protamine sulfate salt from 
salmon grade X, poly(ethylene imine) (PEI) Mw = 25,000 g/mol-1, and 11- 
Mercaptoundecanoic acid (11-MUA) were purchased from Sigma-Aldrich Chemical 
Company (Steinheim, Germany). 21 base pair DNA was synthesized by Eurofins 
MWG Operon (sense strand: 5´-ATGAACTTCAGGGTCAGCTTGC-3´and antisense 
strand: 5´-GCAAGCTGACCCTGAAGTTCAT-3´). Picryl sulfonic acid solution was 
purchased from Fluka (Steinheim, Germany). Tri-sodium citrate dihydrate, sodium 
chloride, sodium hydroxide, nitric acid, hydrochloric acid, and absolute ethanol were 
purchased from Merck (Darmstadt, Germany). Chinese hamster ovarian cells (CHO-
K1 cells)(ATCC No. CCL-61) were grown in 75cm2 culture flasks to 90% confluency. 
Dulbecco's Phosphate buffer saline 1x (DPBS) and Leibovitz's L-15 medium 1x 
without phenol red were purchased from (GIBCO) Invitrogen (Germany). Fetal bovine 
serum was purchased from Biochrom AG (Germany). All glassware was thoroughly 
washed with freshly prepared aqua regia (HCl: HNO3 = 3:1) [Caution! Aqua regia is a 
strong acid], extensively rinsed with Millipore water several times, and oven-dried at 
150 °C for 2-3 h before use. All used solutions filtered through 0.22 µm membrane 
filter (Corning Incorporated, Corning NY 14832, Germany) before use. 
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2.2. Preparation and stabilization of gold nanoparticles 
AuNPs were prepared as described previously using the standard reduction of 
tetrachloroauric(III) acid with sodium citrate [35,36]. Briefly, 1.0 ml of 1% 
HAuCl4·3H2O solution was added to 100 ml of Millipore water and heated under 
reflux until boiling. 2.5 ml of a 1% tri-sodium citrate solution was added under 
vigorous stirring. Boiling was continued for 10 min; after that, the heating mantle was 
removed, and stirring was continued for an additional 15 min. Larger aggregates of 
nanoparticles were removed by centrifugation at 2,450 xg. The pH of AuNPs was 
adjusted to 11 with 1N NaOH, followed by the addition of 11-MUA at a final 
concentration of 0.1 mg/ml. The stabilized particles were purified two times at 15,700 
xg for 10 minutes, and resuspended in 1 mM NaCl [37]. 
 
2.3. Layer-by-Layer (LbL) deposition of polyelectrolytes onto MUA-stabilized 
gold nanoparticles (MUA-AuNPs) 
First layer: the purified MUA-AuNPs were added drop-wise to different concentrations 
of protamine sulfate or PEI 25 KDa to determine the optimum concentration of 
polycation required for coating. The solution was stirred for 30 minutes. The 
nanoparticles were characterized via UV-vis spectroscopy, TEM imaging, size, and 
zeta potential measurement. PEI coated gold nanoparticles (PEI-AuNPs) were 
purified three times at 15,700 xg for 15 minutes. 
Second layer: the purified PEI-AuNPs were added to different concentrations of 21 
bp DNA. After 30 minutes of stirring, the size and ξ-potential of coated particles were 
measured and the optimum concentration for coating was chosen. After that, excess 
DNA was removed by two steps of centrifugation at 15,700 xg for 15 minutes and the 
particles were resuspended in 10 mM NaCl. 
Third layer: the purified DNA/PEI-AuNPs were added to 1mg/ml PEI 25 KDa and the 
solution of nanoparticles was stirred for 30 minutes. The PEI/DNA/PEI-AuNPs were 
purified three times at 15,700 xg for 15 minutes for the removal of excess PEI, and 
resuspended in 10mM NaCl. 
 
 
 
 
Chapter 3  Polyelectrolyte Coated AuNPs  
 - 72 -
2.4. Characterization of the LbL-coated gold nanoparticles 
2.4.1. UV-visible spectroscopy of AuNPs 
UV-vis absorbance spectra of the AuNPs after each coating step were recorded 
using an Uvikon 941 spectrophotometer (Kontron Instruments GmbH). 
2.4.2. Size and zeta potential measurements by dynamic light scattering (DLS) 
For the determination of size and ξ-potential, 0.5 ml of AuNPs was diluted with 1.5 ml 
Millipore water. The samples were thermostated to 25 0C and laser light scattering 
analysis was performed with an incident laser beam of 633 nm at a scattering angle 
of 900 using the Malvern ZetaSizer 3000 HSA (Malvern Instruments GmbH). The ξ-
potential measurements were performed in the standard capillary electrophoresis cell 
of the ZetaSizer 3000 HSA (Malvern Instruments GmbH), measuring the 
electrophoretic mobility at 25 0C.   
2.4.3. TEM image of the gold nanoparticles 
Transmission electron micrographs (TEM) of AuNPs were taken on a Philips CM12 
microscope (FEI, Eindhoven, The Netherlands). Samples were prepared by 
depositing the colloidal gold solution onto a carbon-coated copper grid and air-dried 
before analysis. Several micrographs for sample were taken.  
2.4.4. Stability of LbL-coated AuNPs in different ionic strength 
The effect of different ionic strength on the properties of nanoparticles coated with 
the optimum concentration of protamine was determined. In addition, the stability of 
purified PEI-AuNPs was examined in different ionic strength in order to determine the 
suitable ionic strength for further coating steps with the polyanion (DNA). The purified 
particles were resuspended in different concentrations of NaCl (1, 5, 10, 20, and 30 
mM), and particle size distribution, ξ-potential, and UV-vis absorbance were 
determined. 
2.4.5. Determination of excess polyelectrolyte after purification 
The amount of free polyelectrolytes (PEI and DNA) in the supernatant after 
purification was determined. This was in order to ensure that only a minimal amount 
of PEI was detected in the supernatant. The amount of PEI in the supernatant was 
determined according to the method established by Snyder et al. [38] that uses 2,4,6 
Trinitrobenzenesulfonic acid (TNBS) for the detection of amines. In brief, 25 µl of a 
0.03 M TNBS solution were added to 1 ml of the supernatant containing PEI. After 30 
minutes at room temperature, the absorbance was read at 420 nm using a Uvikon 
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941 spectrophotometer. The concentration of PEI was calculated using a standard 
calibration curve. The amount of free DNA in the supernatant was determined by UV 
measurement at 260 nm using a standard calibration curve. 
 
2.5. Cell culture experiments 
2.5.1. Stability of LbL-coated nanoparticles in cell culture medium 
The stability of AuNPs after each coating step was investigated in serum-free and 
serum-containing culture media. The change in UV-vis spectra, hydrodynamic 
diameter, and ξ-potential were monitored. 
2.5.2. Toxicity experiments 
PEI- , DNA/PEI- , and PEI/DNA/PEI-AuNPs (both crude or purified) were incubated 
with CHO-K1 cells for 4 hours and the cells were then visualized by light scanning 
microscopy for toxicity determination. For the quantitative determination of cell 
viability, CHO-K1 cells were grown in 24-well plates at an initial density of 38,000 
cells per well. 20 hours after plating, the culture medium was removed, the cells were 
washed with PBS, and a certain volume of purified PEI-AuNPs was added to the 
different volumes of culture media containing serum. After 4 hours, the medium was 
replaced with fresh culture medium. 48 hours later, cells were prepared for flow 
cytometry analysis as described previously [39]. In brief, floating cells were collected 
and combined with adherent cells after trypsinization. The pooled cells were washed 
twice with PBS, resuspended in 500 µl PBS, and propidium iodide was added at a 
concentration of 1 µg/ml to stain the dead cells. Measurements were taken on a 
FACS Calibur (Becton Dickinson, Germany) using CellQuest Pro software (Becton 
Dickinson, Germany) and evaluated by WinMDI 2.8 software (©1993–2000 Joseph 
Trotter). 20,000 cells were counted for each sample. The propidium iodide emission 
was measured with a 670 nm longpass filter. The fraction of propidium iodide 
negative cells was used to calculate cell viability. The cell population and the number 
of propidium iodide negative cells in the samples were normalized to the untreated 
CHO-K1 cells. 
2.5.3. Cellular uptake experiments 
CHO-K1 cells were incubated with culture medium and serum containing DNA/PEI- 
and PEI/DNA/PEI-AuNPs for 6 hours. Thereafter, the cells contained in three flasks 
were washed two times with PBS, detached from the flask by trypsinization, pelleted, 
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and again washed with PBS. For the determination of the Au3+ content via inductively 
coupled plasma-optical emission spectroscopy (ICP-OES) the cell pellet was air 
dried, dissolved in 500 µl of freshly prepared aqua regia [Caution! Aqua regia is a 
strong acid] and diluted to 5 ml with Millipore water. ICP-OES analysis of the samples 
was performed on a JY-70 PLUS (Jobin Yvon Instruments S.A.) with a plasma flow of 
16 L/min argon. All standards were made with gold (III) chloride at concentrations of 
1, 10, 100 and 1,000 ppm. The measured number of Au3+ was used to calculate the 
number of AuNPs, as described by Cumberland et al. [40] and related to the total 
number of cells. The number of total cells was determined by counting the cells of 
one 75cm2 culture flasks in a Neubauer Chamber. The samples for cell counting 
were incubated with AuNPs in the same way as samples for ICP-OES 
measurements. Cell samples treated as described above but without addition of 
AuNPs were used as controls for background subtraction. 
 
3. Results and discussion 
3.1. Coating of stabilized MUA-AuNPs with different polycations 
3.1.1. Coating and characterization of stabilized MUA-AuNPs with protamine 
Protamine sulfate was used as a positive polyelectrolyte that could coat the 
negatively charged MUA-AuNPs. A uniform polyelectrolyte coating is desired, since 
such a coating is favorable for the formation of colloidally stable coated 
nanoparticles. It has been shown previously that a low concentration of added 
polyelectrolyte causes particle aggregation due to the electrostatic attraction of 
partially coated and uncoated colloids [41-43]. At the same time, polyelectrolyte 
excess should be limited, as to maintain conditions that are practical for synthesis 
and handling. Therefore, the determination of the optimal concentration is a 
necessary step in overcoming this obstacle. Figure 2 shows the hydrodynamic 
diameter and polydispersity index (PI) of purified MUA-AuNPs suspended in 1mM 
NaCl coated with different concentrations of protamine sulfate. The hydrodynamic 
diameter of MUA-AuNPs increased from 21.6 ± 0.2 to 25.2 ± 0.6 nm after being 
coated with 6 µg/ml protamine. The diameter further increased with increasing 
protamine concentration. The highest hydrodynamic diameter was observed with 
1000 µg/ml protamine (35.4 ± 0.5 nm). With respect to the polydispersity index, 
considerable differences were observed with different concentrations of protamine. 
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The PI of MUA-AuNPs coated with 6 and 10 µg/ml protamine was about 0.6, which 
indicates the presence of polydispersed particles in the preparation. With a higher 
concentration of protamine (100 and 500 µg/ml), the PI reduced to about 0.4 but it 
increased again with 1000 µg/ml to about 0.55. 
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Figure 2: The hydrodynamic diameter (white columns) and the polydispersity index (rhombs) 
of different protamine concentrations coated MUA-AuNPs at 1mM NaCl 
 
Several methods are applied to characterize particles, especially in terms of size, but 
none of them is ever fully satisfactory. Therefore, a combination of at least two 
methods is highly recommended, with one of the methods being microscopic in 
nature [44]. Therefore, the produced particles were further characterized via TEM 
imaging. Figure 3 shows the TEM images of two different concentrations of 
protamine sulfate coated MUA-AuNPs. The image of 10 µg/ml protamine coated 
nanoparticles shows both single and aggregated particles. These aggregated 
particles could be attributed to incomplete surface coverage of the nanoparticles with 
protamine. The presence of these different species of partially coated and uncoated 
particles causes the aggregation which is reflected by the high PI readings. In 
contrast, particles coated with 100 µg/ml protamine were mostly spherical and 
monodispersed, indicating complete surface coverage of nanoparticles. These TEM 
micrographs agreed very well with the measurement of the hydrodynamic diameter.  
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Figure 3: TEM images of 10 and 100 µg/ml protamine coated AuNPs 
 
The zeta potential (ξ-potential) not only plays an important role in the stability of 
nanoparticles, but is also considered one of the most important parameters 
characterizing successful deposition of polyelectrolytes on colloidal surfaces. 
Therefore, to establish the successful coating of nanoparticles with protamine and 
the cause of aggregation at lower protamine concentrations, zeta potential 
measurements were carried out. The ξ-potentials of lower concentrations of 
protamine coated nanoparticles were about 15.8 and 29 mV for 6 and 10 µg/ml 
protamine, respectively. However, the highest ξ-potential (45.2 mV) was observed 
with 100 µg/ml protamine, as shown in Figure 4. Particle aggregation is less likely to 
occur for charged particles with a zeta potential higher than 30 mV, due to 
electrostatic repulsion forces between similarly charged particles [15]. From the 
particle size distribution, TEM image, and ξ-potential results, 100 µg/ml protamine 
was chosen as the optimum concentration for coating of MUA-AuNPs. 
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Figure 4: Zeta potential of different concentrations of protamine coated MUA-AuNPs at 1 
mM NaCl 
 
It is known that the ionic strength of a solution is important in order to reduce the 
stiffness of a polymer, allowing it to wrap around nanoparticles. Unfortunately 
increasing the ionic strength also causes an aggregation of nanoparticles [14, 45]. It 
is therefore necessary to find a balance between chain flexibility and the stability of 
nanoparticles.  We determined the stability of 100 µg/ml protamine coated MUA-
AuNPs at different ionic strength by monitoring particle size distribution, zeta 
potential measurements, and changes in surface plasmon resonance (SPR). The 
hydrodynamic diameter of protamine coated nanoparticles increased from 29 nm to 
approximately 58 nm, with increasing ionic strength from 1 to 30 mM NaCl (data not 
shown). In contrast, there was no significant difference in the ξ-potential of coated 
nanoparticles at different ionic strength (data not shown). Figure 5 shows the change 
in the SPR of MUA-AuNPs before and after coating with protamine at different ionic 
strength. Only a slight red shift in SPR after coating with protamine at 1, 5, and 10 
mM NaCl was observed, which is due to a change in the refractive index of the 
environment surrounding the nanoparticles. This change is a result of an attached 
polymer layer around the particles, and is also an indication of the successful coating 
of nanoparticles with the polymers [46, 47]. However, the SPR shifted about 10 nm 
after the coating of nanoparticles at 30 mM NaCl, which is considered a sign of 
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aggregation, reflected by the increased hydrodynamic diameter. The reported 
increase in size could be attributed to instability and the aggregation of particles at 
higher ionic strength (30 mM NaCl), since increasing the ionic strength decreases the 
Debye-Hückel length, allowing the Van der Waals attractive forces to become more 
pronounced and thereby counteract the repulsive forces [48]. Therefore, 1 mM NaCl 
was chosen as suitable ionic strength for coating of MUA-AuNPs, since it was 
sufficient for wrapping protamine around nanoparticles. For the reasons previously 
mentioned, it is recommended to work at the lowest possible ionic strength when 
coating nanoparticles with polyelectrolyte via LbL approach [49]. 
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Figure 5: Effect of different ionic strength on UV-vis absorbance of MUA-AuNPs (solid line) 
and protamine-AuNPs (dashed line) 
 
The major challenge in the use of LbL technology on colloidal particles is the 
purification and removal of excess polyelectrolyte before subsequent coating steps, 
as to avoid the formation of polyelectrolyte complexes and aggregations in bulk 
solution [9, 10]. Therefore, several methods, such as centrifugation at high speed 
(about 15,700 xg) and ultrafiltration, were evaluated to purify protamine-AuNPs from 
free unbound protamine before coating with the polyanion. Unfortunately, the 
particles aggregated during the purification process and there was no suitable 
method for the removal of excess protamine. This could be attributed to the low 
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molecular weight of protamine (only about 5 KDa). Hence, it could be that protamine 
is not large enough to maintain nanoparticle stabilization during purification, since the 
polymer length must be long enough to achieve colloidal stability while being short 
enough to minimize interparticle cross-bridging and flocculation [11, 49, 50]. Due to 
the difficulty of the purification of nanoparticles with protamine, it was decided that 
protamine was not suitable for the coating of small AuNPs via the LbL technique. 
 
3.1.2. Coating and characterization of stabilized MUA-AuNPs with PEI 25 KDa 
In the next step PEI was chosen for coating MUA-AuNPs. In contrast to protamine, 
PEI is a branched polymer with high molecular weight (25 KDa). Therefore, it could 
be better for the coating of nanoparticles via the LbL technique than protamine. An 
ionic strength of 1 mM NaCl was chosen as suitable ionic strength for the coating of 
purified MUA-AuNPs with PEI 25 KDa in accordance with previous results and 
reported by Caruso et al. [49, 50]. Figure 6 shows the hydrodynamic diameter and 
polydispersity index of MUA-AuNPs coated with different concentrations of PEI 
before (crude) and after purification. The particles were coated well with three 
different concentrations, as observed from size and ξ-potential measurements. 
However, the nanoparticles coated with 0.1 mg/ml PEI aggregated during the 
purification process and the hydrodynamic diameter increased to about 50 nm with a 
high PI of about 0.7, which indicates that this concentration failed to stabilize the 
particles. However, both 0.5 and 1 mg/ml PEI worked well during coating and 
purification. 1 mg/ml was chosen as the optimum concentration for coating because 
PEI coated AuNPs (PEI-AuNPs) at this concentration had lower hydrodynamic 
diameters after purification  (about 20 nm) and a PI approximately 0.2, while the PI 
after coating with 0.5 mg/ml PEI was about 0.4. In addition, 1 mg/ml PEI-AuNPs had 
higher ξ-potentials, even after purification. It was 35.8 mV, as shown in Figure 7. 
 
 
 
 
 
 
 
Chapter 3  Polyelectrolyte Coated AuNPs  
 - 80 -
0
10
20
30
40
50
60
crude purified crude purified crude purified
D
ia
m
e
te
r 
[nm
]
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
P
olydisp
e
rsity
 Ind
e
x
0.1mg/ml 0.5mg/ml 1.0mg/ml
Figure 6: The hydrodynamic diameter (white columns) and the polydispersity index (rhombs) 
of different concentrations of PEI coated MUA-AuNPs at 1 mM NaCl 
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Figure 7: Zeta potential of different concentrations of PEI coated MUA-AuNPs at 1 mM NaCl 
 
In order to rule out the formation of nanoparticle aggregates on adsorption of the 
polyelectrolytes, the coated particles were also characterized by using TEM. Figure 8 
shows representative TEM images of 1 mg/ml PEI coated MUA-AuNPs. It can be 
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seen that the particles were well separated, with no apparent signs of aggregation. It 
should also be noted that no broadening of the SPR peak of PEI-AuNPs occurred as 
a result of coating with PEI, suggesting the absence of aggregated nanoparticles 
(data not shown). Furthermore, the PEI-AuNPs were found to be colloidally stable for 
more than one month (data not shown). 
 
 
Figure 8: TEM image of 1.0 mg/ml PEI-AuNPs  
 
Because successful removal of the excess polyelectrolyte is a critical obstacle for 
LbL coating, the amount of free PEI in the supernatant after purification was 
determined. Table 1 shows that after three purification steps only a negligible amount 
of free PEI was observed, which indicates the removal of the free PEI from the 
colloid.  
 
Table 1: Initial concentration of PEI-AuNPs and its concentration in the discarded 
supernatant after purification  
Layer Initial polyelectrolyte 
concentration 
Purification 
step 
Polyelectrolyte concentration 
in supernatant 
PEI 1.0 mg/ml 1 0.7312 mg/ml 
  2 0.0138 mg/ml 
  3 0.0005 mg/ml 
 
Furthermore, the purified particles did not show any signs of toxicity within the CHO-
K1 cell as shown in Figure 9. The cells were flat and spreaded, as were the control 
PEI-AuNPs 
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cells that were treated with buffer only. The cells that were incubated with crude 
(unpurified) PEI-AuNPs shrunk and died due to the presence of free PEI, which is 
considered the main cause of cell death [31]. This result was further confirmed by 
FACS analysis to determine the viability of CHO-K1 cells after incubation with 
different volumes of purified PEI-AuNPs. Figure 10 showed nearly no toxic effects on 
the viability of CHO-K1 cells at different Au3+ concentrations.  
 
 
Figure 9: Light microscopy images of CHO-K1 cell after incubation with crude (A) and 
purified (B) PEI-AuNPs at Au+3 23.3 µM and control cell without particles (C), each bar 
indicates 10 µm 
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Figure 10: Relative viability of CHO-K1 cells after incubation with purified PEI-AuNPs, 
determined with propidium iodide staining followed by FACS analysis 
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Nucleic acids like DNA and siRNA are negatively charged, rigid, and stiff biopolymers 
[21]. Therefore, in order to coat PEI-AuNPs with this stiff nucleic acid and achieve the 
complete wrapping of nucleic acid around the small AuNPs, it is important to choose 
a suitable ionic strength that will allow for a reduction in the stiffness of DNA or 
siRNA, yet still maintain colloidal stability. We determined the stability of purified PEI-
AuNPs at different ionic strength by monitoring the nanoparticle's change in size and 
zeta potential. Figure 11 shows the hydrodynamic diameter and polydispersity index 
of crude PEI-AuNPs, as well as the values after purification and resuspension in a 
different concentration of NaCl. The particles showed good stability in different ionic 
strength, with only a slight increase in PI of purified particles suspended in 30 mM 
NaCl, which was about 0.4. The ξ-potential of purified particles slightly decreased 
with increasing ionic strength, as shown in Figure 12.   
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Figure 11: Influence of the ionic strength on the hydrodynamic diameter (columns) and 
polydispersity index (rhombs) of 1.0 mg/ml PEI-AuNPs after purification 
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Figure 12: Influence of the ionic strength on the ξ-potential of 1.0 mg/ml PEI-AuNPs after 
purification  
 
These results show that the purified PEI-AuNPs has good stability at different ionic 
strength (1-30 mM NaCl). The lowest possible ionic strength (10mM NaCl) required 
for reducing DNA stiffness and allowing for complete wrapping around AuNPs was 
selected. 
 
3.3. Coating and characterization of purified PEI-AuNPs with polyanion (21 bp 
DNA) 
It is known that full DNA wrapping is obtained for salt concentrations corresponding 
to the Debye-Hückel screening length larger than 0.2 nm-1, as calculated by Kunze 
and Netz on the salt-induced DNA-histone complexation [12]. Therefore, 10 mM 
NaCl, which is equivalent to a Debye-Hückel screening length 0.32 nm-1, was chosen 
as the ionic strength able to reduce the stiffness of DNA and cause complete 
wrapping of it around AuNPs. Purified PEI-AuNPs coated with different 
concentrations of DNA were characterized by determining particle size distribution 
and zeta potential. Figure 13 revealed that DNA at concentration of 0.5, 1 and 1.5 µM 
DNA successfully coated nanoparticles. However, the particles coated with 0.5 µM 
DNA aggregated during purification, with a dramatic increase in size (100 nm). This 
aggregation indicates that 0.5 µM DNA is not concentrated enough to keep the 
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particle stable during purification, while particles coated with 1 and 1.5 µM DNA 
showed good stability after purification. However, 1 µM DNA had a high PI before 
and after purification. 
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Figure 13: The hydrodynamic diameter (white columns) and the polydispersity index 
(rhombs) of different concentrations of DNA coated PEI-AuNPs before (crude) and after 
purification (purified) 
 
In addition, the ξ-potential of 0.5 and 1 µM DNA after purification significantly 
decreased and became nearly neutral, as shown in Figure 14. 1.5 µM DNA showed 
the highest ξ-potential before and after purification, -67.2 ± 1.7 and -37.6 ± 1.7 mV 
respectively, which indicates the stability of coated particles. This also demonstrates 
the inversion of ξ-potential from positive to negative, signifying the successful 
wrapping of DNA around nanoparticles. Therefore, 1.5µM DNA was chosen as 
suitable concentration for coating of PEI-AuNPs and the produced DNA/PEI-AuNPs 
were monodispersed and free from aggregate, as shown in TEM images in Figure 
15.  
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Figure 14: The ξ-potential of different concentrations of DNA coated PEI-AuNPs before 
(crude) and after purification (purified) 
 
 
Figure 15: TEM image of 1.5 µM DNA/PEI-AuNPs 
 
In order to confirm successful purification, the amount of free DNA in the supernatant 
was determined. Table 2 shows only trace amounts of DNA remained after the 
second purification step. Hence, there was no chance of polyelectrolyte complex 
formation during the last step of coating with PEI. In addition, both crude and purified 
particles did not show any signs of toxicity when incubated with CHO-K1 cell for 4 
DNA/PEI-AuNPs 
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hours (data not shown). The absence of toxicity with crude particles could be 
attributed to the fact that DNA is a biopolymer and not toxic to the cells. 
 
Table 2: Initial concentration of DNA coated PEI-AuNPs and the concentration in the 
discarded supernatant after purification.  
Layer Initial polyelectrolyte 
concentration 
Purification 
step 
Polyelectrolyte concentration 
in supernatant 
DNA 1.5 µM 1 1.30 µM 
  2 0.07 µM 
 
3.4. Fabrication of polyelectrolyte coated gold nanoparticles via LbL 
technology 
According to the optimal parameters identified earlier, MUA-AuNPs were assembled 
via the LbL technique. The first layer polycation was PEI, the second layer was 
negatively charged DNA, and the third was again PEI, which formed LbL-coated 
PEI/DNA/PEI-AuNPs. The successful polyelectrolyte deposition was monitored by 
dynamic light scattering (DLS), ξ-potential measurement, UV-vis absorbance 
spectroscopy, and TEM. Figure 16 shows that the hydrodynamic diameter increased 
during coating from 21.6 ± 0.5 nm (MUA-AuNPs) to 25.5 ± 0.8 nm (PEI/DNA/PEI-
AuNPs).  Additionally, a reversal in ξ-potential signified the deposition of each 
polyelectrolyte layer (Figure 17). The ξ-potential slightly decreased after purification 
due to the removal of free unbound polyelectrolyte. 
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Figure 16: Effect of subsequent coating steps of AuNPs during LbL build-up on the 
hydrodynamic diameter (white columns) and the polydispersity index (rhombs) of AuNPs 
before (crude) and after purification (purified) 
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Figure 17: Effect of subsequent coating steps of AuNPs during LbL build-up on the ξ-
potential of AuNPs before (crude) and after purification (purified) 
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The change in the surface plasmon resonance of gold nanoparticles was used to 
differentiate between polymer adsorption onto the AuNPs surface and interparticulate 
bridging and aggregation [49, 51].  The UV-vis spectra of AuNPs on Figure 18 shows 
only a small red shift (1 and 2 nm) in the SPR, which is attributed to subsequent layer 
deposition and increases in nanoparticle size, along with an overall decrease in the 
maximum absorbance intensity. This decrease is attributed to dilution effects during 
purification steps. To further characterize the LbL buildup, TEM images of the 
nanoparticles were taken after the completion of LbL coating. Figure 19 revealed that 
the nanoparticles were mainly spherical and well separated from each other, without 
any signs of aggregation. The polyelectrolyte coating around the nanoparticles could 
not be seen, which is due to the lack of contrast between the nanoparticles and the 
background at the given magnification. 
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Figure 18: UV-vis spectra of AuNPs coated with polyelectrolyte 
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Figure 19: TEM images of PEI/DNA/PEI-AuNPs 
 
In most cases, self assembled aggregates of PEI and nucleic acid suffer from severe 
aggregation when subjected to the high ionic strength of biological fluids [33, 52], and 
the initial size of these complexes may increase to several micrometers [33]. This 
feature would make the fabrication of LbL-coated nanoparticles tedious and would 
render their application in cell culture pointless, because the nanoparticles would no 
longer be monodisperse. Therefore, the AuNPs were exposed to cell culture medium 
with and without fetal bovine serum, and the hydrodynamic diameter, ξ-potential, and 
the change in SPR were monitored. Regardless of the type of the outer layer (PEI or 
DNA) the hydrodynamic diameter of AuNPs only increased by a factor of 2.1 to 2.5 in 
culture medium containing serum. This increase in size would be attributed to the 
adsorption of proteins on the surface of AuNPs, as already demonstrated with 
unmodified and other oligonucleotide-modified AuNPs [53, 54]. In contrast, the 
particle size increased by a factor of 7 to 10 in serum-free culture medium as shown 
in Figure 20. This change in the hydrodynamic diameter was also reflected in the red 
shift of the SPR. The maximum plasmon peak (λmax) was 530, 531, and 535 nm for 
PEI-, DNA/PEI-, and PEI/DNA/PEI-AuNPs in culture medium containing serum (data 
not shown). In serum-free culture medium, the individuality of AuNPs was lost, as 
demonstrated with λmax values of 573, 579, and 583 nm for PEI-, DNA/PEI-, and 
PEI/DNA/PEI-AuNPs, respectively (data not shown). These results corroborate the 
hypothesis that serum proteins are necessary for the nanoparticles stabilization. 
PEI/DNA/PEI-AuNPs 
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Figure 20: The hydrodynamic diameter of subsequent coating steps of AuNPs layers in 
water (░), serum containing culture medium (▓), and serum free culture medium (█) 
 
Moreover, the ξ-potential of all particle types was negative after incubation in culture 
medium (Figure 21). More specifically, the negative ξ-potential of DNA/PEI-AuNPs 
became more positive, while PEI- and PEI/DNA/PEI-AuNPs showed a reversal of the 
charge. In addition, the purified PEI/DNA/PEI-AuNPs did not show any signs of 
toxicity after incubation with CHO-K1 cells, while crude unpurified particles caused 
severe toxicity to the cells from the presence of free unbound PEI (Figure 22). 
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Figure 21: The ξ-Potential of subsequent coating steps of AuNPs in water (░), serum-
containing culture medium (▓), and serum-free culture medium (█) 
 
 
 
Figure 22: Light microscopy images of a CHO-K1 cell after incubation with crude (A) and 
purified (B) PEI/DNA/PEI-AuNPs at Au+3 23.3 µM and control cell without particles (C). Each 
bar indicates 10 µm 
 
In order to determine if the particles are taken up by cells and to obtain quantitative 
data for the number of AuNPs per cell, CHO-K1 cells were incubated with DNA/PEI- 
and PEI/DNA/PEI-AuNPs for 6 hrs in culture medium containing serum, and the Au+3 
content was determined by ICP-OES. Both types of particles were successfully taken 
up by the cells, and the amount of the particles per cell strongly depended on the 
type of the top layer. CHO-K1 cells internalized more DNA/PEI-AuNPs (66.1 x 103) in 
relation to PEI/DNA/PEI-AuNPs (37.7 x 103) (Figure 23). This significant difference in 
A B C 
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the cellular uptake of AuNPs that are of nearly similar size but has different outer 
layers suggests that surface properties may strongly influence internalization of the 
nanoparticles within cells. 
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Figure 23: The cellular uptake of AuNPs. The number of AuNPs per cell as determined by 
ICP-OES and cell counting after 6 hours of incubation in serum containing culture medium as 
a function of surface modification. For each measurement cells from 3 culture flasks (75 cm2 
each) were pooled to obtain values within the calibration range, bars are averages of two 
measurements of one representative experiment of two independent ones. 
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4. Summary and conclusion 
By controlling the polyelectrolyte type, concentration, ionic strength of the 
surrounding medium, and particle surface properties, AuNPs were successfully 
assembled with polyelectrolytes via the LbL approach for nucleic acid delivery. 1.0 
mg/ml PEI 25 KDa was chosen as the positively charged polyelectrolyte at 1 mM 
NaCl, while 1.5 µM of 21 bp DNA was selected as a model negatively charged 
polyelectrolyte at 10 mM NaCl. The resulting particles were small (~ 26 nm), and had 
a narrow size distribution with a polydispersity index of about 0.4. Although a high 
toxicity was observed with the formulation containing branched PEI 25 KDa, our 
purified particles did not show any visible signs of toxicity after incubation with CHO-
K1 cells, due to removal of free unbound PEI from the particles. Moreover, the 
produced particles showed good stability in culture medium containing serum, which 
is attributed to the stabilization of the nanoparticles by serum proteins. This is 
considered a prerequisite for successful cellular uptake of monodisprese particles. In 
addition, both types of particles (DNA/PEI- and PEI/DNA/PEI-AuNPs) were 
successfully taken up by CHO-K1 cells and the amount of AuNPs per cell depended 
on the type of the top layer. Overall, these results demonstrated that delivery of 
nucleic acid can be achieved via LbL technology with colloidal gold as a template. 
These established parameters bring to fruition the successful fabrication of well 
defined and homogenously distributed nano-carriers for siRNA delivery via the LbL 
technique. 
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Abstract 
Although uptake into cells is highly complex and regulated, heterogeneous particle 
collectives are usually employed to deliver small interfering RNA (siRNA) to cells. 
Within these collectives, it is difficult to accurately identify the active species, and a 
decrease in efficacy is inherent to such preparations. Here, we demonstrate the 
manufacture of uniform nanoparticles with the deposition of siRNA on gold in a 
Layer-by-Layer approach, and we further report on the cellular delivery and siRNA 
activity as functions of surface properties. 
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Introduction 
The creation and design of nano-sized carriers for the delivery of nucleic acids such 
as small interfering RNAs (siRNAs) have recently gained interest because of their 
possible clinical applications [1, 2]. The interaction with cell membranes is of central 
importance for these delivery systems, because this represents the key event in the 
regulation of the uptake process. The multiple portals of entry into mammalian cells 
strongly vary with regard to the nature and size of the cargo, as do their intracellular 
destination and fate [3]. Consequently, the pathway of cellular entry will determine if 
the respective nucleic acid is unloaded at its site of action and if it is effective or not. 
Therefore, in order to deliver siRNA-loaded nanoparticles to specific intracellular 
destinations to elicit a distinctive biological effect, it is optimal to apply small, 
monodisperse nanoparticles with a defined zeta potential and surface chemistry. 
Although the field of siRNA therapeutics has made significant progress, the effective 
delivery of siRNA remains a challenge that must be addressed before clinical use of 
siRNA becomes a preferred technique [1, 4, 5]. A plethora of materials that can form 
nano-sized complexes with siRNA have previously been intensively investigated [6, 
7]. Most studies have focused on cationic lipids and polymers, which form random 
self-assembled aggregates with nucleic acids that are often larger than 100 nm. 
These systems are generally heterogeneous and poorly-defined particle collectives 
[8-11]. For example, a commonly used system involves forming nanoparticles with 
poly(ethylene imine) (PEI) and nucleic acids. The resulting collective contains 
different particle species that are in equilibrium with free polymer (about 86%) [12]. 
The heterogeneity of this system and the existence of different sub-populations in 
such random preparations lead to a decrease in efficacy, and this also complicates 
the interpretation of experimental results tremendously since it is not evident which 
particular sub-species of the preparation is responsible for the overall biological 
effect. Furthermore, toxic effects that may be exhibited by only a fraction of the 
preparation may appear to be intrinsic properties of the whole collective. Because 
endocytosis is governed by highly sophisticated and well-regulated principles and 
because heterogeneous particle collectives are associated with all of the 
aforementioned disadvantages, it is clear that new strategies for the fabrication of 
efficient nanocarriers are essential to advance the field. 
While current approaches, which have focused on adjusting the size and surface 
properties of nanoparticles, are excellent models to help understand drug targeting 
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principles and cellular uptake [13-17], they are not ideally suited to transport highly 
charged macromolecules such as siRNA. Still, gold nanoparticles (AuNPs) have 
preciously been used to deliver oligonucleotides or plasmid DNA [18-20] and even 
siRNA [21, 22] into cells. Very recently, Mirkin and co-workers attached siRNA 
molecules to the surface of AuNPs via a thiol group [22]. The polyvalent 
siRNA/nanoparticle conjugates showed a 6 times greater half-life and prolonged 
gene knock down compared to free RNA duplexes. While these approaches 
demonstrate the general applicability of AuNPs as delivery vehicle, in some cases, 
AuNPs seemed to aggregate after assembly with nucleic acids [18, 21], the delivered 
nucleic acid showed low activity inside cells [20], or the efficacy of the nucleic acid 
relied on an additional transfection reagent [19].  
We hypothesized that a Layer-by-Layer (LbL) strategy would allow us to use 
monodisperse AuNPs as a template for the manufacture of a carrier that remains 
monodisperse during assembly and delivers active siRNA into cells, thereby 
circumventing the limitations of previous systems. Although the LbL deposition of 
oppositely charged polyelectrolytes is an established method for the fabrication of 
thin films on flat solid surfaces and microparticles [23, 24], the coating of 
nanoparticles presents a tremendous challenge. This is because many problems are 
associated with the wrapping of polyelectrolytes around nanoparticles with high 
curvature such as aggregation due to crosslinking of the particles by the 
polyelectrolyte chains and the separation of the unbound polyelectrolyte from the 
coated particles [25-27]. Here, we present a first proof of concept that even small 
nanoparticles can be modified with therapeutically relevant siRNA molecules in a LbL 
approach, and we report on the experimental parameters of their fabrication as well 
as their cellular delivery. 
AuNPs as a core bear several advantages including straightforward synthesis, easy 
surface modification, availability in different size ranges with narrow size distribution, 
and finally high biocompatibility with cells or tissues [28-30].  
 
Materials and method  
Polyelectrolytes used for multilayer deposition were poly(ethylene imine) (PEI) Mw = 
25,000 g/mol-1 (Sigma-Aldrich) and siRNA synthesized by Eurofins MWG Operon 
(siRNA against EGFP, sense strand: 5´-GAACUUCAGGGUCAGCUUGCCG-3´ and 
antisense strand: 5´-GCAAGCUGACCCUGAAGUUCAU-3´, non-targeted siRNA, 
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sense strand: 5´- GCAAGCTGACCCTGAAGTTCAT-3´ and antisense strand: 5´- 
ATGAACTTCAGGGTCAGCTTGC-3´). AuNPs were prepared as described 
previously using the standard reduction of tetrachloroauric(III) acid with sodium 
citrate [31, 32]. Briefly, 1.0 ml of 1% AuCl4·3H2O solution was condensed to 100 ml 
and heated under reflux until boiling. 2.5 ml of a 1% trisodium citrate solution were 
added under vigorous stirring. Boiling was continued for 10 min. Larger aggregates 
were removed by centrifugation at 2,450 xg. The pH of AuNPs was adjusted to 11 
with 1N NaOH, followed by the addition of 11-MUA at a final concentration of 0.1 
mg/ml. The stabilized particles were purified two times at 15,700 xg for 10 minutes, 
and resuspended in 1 mM NaCl. Each coating step with PEI or siRNA was performed 
for 30 min after the addition of the gold nanoparticles to the respective, stirring 
polyelectrolyte solution. For the assembly of the first and third layer, PEI was used at 
a final concentration of 1.0 mg/ml. siRNA was added at a final concentration of 2.0 
µM to purified PEI-AuNPs particles. Purification of the crude AuNPs was performed 
two or three times at 15,700 xg for 15 min, and the AuNPs were resuspended in 10 
mM NaCl. The amount of PEI in the supernatant was determined according to the 
method of Snyder et al. [33] that uses 2,4,6-Trinitrobenzenesulfonic acid (TNBS) for 
the detection of amines. In brief, 25 µl of a 0.03 M TNBS solution were added to 1 ml 
of the supernatant containing PEI. After 30 minutes at room temperature, the 
absorbance was read at 420 nm using an Uvikon 941 spectrophotometer (Kontron 
Instruments GmbH). The concentration of PEI was calculated using a standard 
calibration curve. The amount of siRNA was determined by UV measurements 
(Uvikon 941 spectrophotometer) at 260 nm using a standard calibration curve. 
For the determination of the size and zeta potential, 0.5 ml of AuNPs were either 
diluted with 1.5 ml millipore water or culture medium (Leibovitz’s without phenolred, 
Invitrogen) with or without fetal bovine serum (Sigma-Aldrich). The samples were 
thermostated to 25 °C and laser light scattering analysis was performed with an 
incident laser beam of 633 nm at a scattering angle of 90° using the Malvern 
ZetaSizer 3000 HSA software (Malvern Instruments GmbH). The sampling time was 
set automatically. Three measurements each with 10 sub-runs were performed for 
each sample. The count rate for all dispersants was lower than 10 Kcps. The 
intensity of the autocorrelation function of the sample was deconvolved with the non-
negatively constrained least squares (NNLS) algorithm because it provides a high 
resolution analysis and the quality of the fitting passed in all measurements during 
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each coating step. The zeta potential measurements were performed in the standard 
capillary electrophoresis cell of the ZetaSizer 3000 HSA (Malvern Instruments 
GmbH), measuring the electrophoretic mobility at 25 °C. UV-vis absorbance spectra 
of the AuNPs were recorded using an Uvikon 941 spectrophotometer (Kontron 
Instruments GmbH). Transmission electron micrographs (TEM) of AuNPs were taken 
on a Philips CM12 microscope (FEI, Eindhoven, The Netherlands). Samples were 
prepared by depositing the colloidal gold solution onto a carbon-coated copper grid 
and air-dried before analysis. Several micrographs of one sample were taken. For 
statistical evaluation, the diameter of 500 AuNP cores was measured using Image J 
for microscopy (NIH Image). For the determination of the concentration of AuNPs in 
solution, 500 µl of a sample containing AuNPs was mixed with 200 µl freshly 
prepared aqua regia [Caution! Aqua regia is a strong acid] and diluted to 5 ml with 
Millipore water. The Au3+ content of the solution was determined by ICP-OES 
analysis on a JY-70 PLUS (Jobin Yvon Instruments S.A.). The plasma flow was 16 
L/min argon. All standards were made with gold(III) chloride at a concentration of 1, 
10, 100 and 1,000 ppm. The measured concentration of Au3+ was divided by the 
number of gold atoms per particle to obtain the concentration of AuNPs in solution. 
The number of gold atoms per particle was calculated using the particle diameter, the 
density of bulk gold and the molecular weight of gold, the value was 11.5 x 104 atoms 
per particle. The number of siRNA molecules per particle was calculated using the 
amount of siRNA adsorbed on the AuNP surface (amount of siRNA added - amount 
siRNA removed during purification (Table 1) and the concentration of particles in 
solution. 
For cellular uptake studies (ICP-OES and TEM), CHO-K1 cells (ATCC No. CCL-61) 
were used. The cells were grown in 75cm2 culture flasks to 90% confluency. Cells 
were incubated with culture medium with serum containing siRNA/PEI- and 
PEI/siRNA/PEI-AuNPs for 6 hours. The applied concentration of AuNPs is indicated 
in the figure legends. Thereafter, cells of three flasks were washed two times with 
PBS, detached from the flask by trypsinization, pelleted, and again washed with PBS. 
For the determination of the Au3+ content by ICP-OES the cell pellet was air dried, 
dissolved in 500 µl of freshly prepared aqua regia [Caution! Aqua regia is a strong 
acid] and diluted to 5 ml with Millipore water. ICP-OES analysis of the samples was 
performed on a JY-70 PLUS (Jobin Yvon Instruments S.A.) with a plasma flow of 16 
L/min argon. All standards were made with gold(III) chloride at a concentration of 1, 
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10, 100 and 1,000 ppm. The measured number of Au3+ was used to calculate the 
number of AuNPs as described above and related to the total number of cells. The 
number of total cells was determined by counting the cells of one 75cm2 culture 
flasks in a Neubauer Chamber. The samples for cell counting were incubated with 
AuNPs in the same way as samples for ICP-OES measurements. Cell samples 
treated as described above but without addition of AuNPs were used as controls for 
background subtraction. One representative experiment of two independent ones is 
shown. For TEM experiments, the cell pellet was prepared as described above, then 
fixed with 2% glutaraldehyde in cacodylate buffer over night, and rinsed with 0.1 M 
cacodylate buffer. Postfixation was performed for 1h 45 min in 1% osmium tetroxide 
[Caution! Extremely toxic] at 4°C. After several washing steps with 0.1 M cacodylate 
buffer, the sample was embedded in agarose, and dehydrated in a graded series of 
ethanol (70, 80, 90, 95, and 100%). Thereafter, the sample was embedded in Epon. 
Ultrathin sections with a thickness of about 70 nm were imaged without further 
contrasting at 120 keV using a Philips CM12 microscope (FEI, Eindhoven, The 
Netherlands). 
For gene silencing experiments, CHO-K1 cells stably expressing EGFP (CHO-
K1/EGFP) were applied. These cells were generated by transfecting linearized 
pEGFP-N1 vector into CHO-K1 cells as described previously [34]. CHO-K1/EGFP 
cells were grown in 24-well plates at an initial density of 38,000 cells per well. 20 
hours after plating, the culture medium was removed, cells were washed with PBS, 
and siRNA/PEI- or PEI/siRNA/PEI-AuNPs were added in various concentrations to 
the culture medium containing serum as indicated in the figure legends. After 6 
hours, the medium was replaced with fresh culture medium. 48 hours later, cells 
were prepared for flow cytometry analysis on a FACS Calibur (Beckton Dickinson) 
and measurements of the mean fluorescence intensity (MFI) of EGFP and cell 
viability were performed as described previously [34]. The values of the MFI were 
used to calculate the knock-down of EGFP relative to untreated cells. All experiments 
were performed in triplicate and expressed as mean ± standard deviation. One 
representative experiment of three independent ones is shown. 
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Results and discussion 
In this study, AuNPs were synthesized as spherical, homogeneous, and free of 
aggregates. They had a size of 15.5 ± 1.2 nm as determined by transmission electron 
microscopy (TEM) (Figure 3). 
For the LbL coating of the nanoparticles we envisioned a strategy that is illustrated in 
scheme 1. First, 11-mercaptoundecanoic acid (MUA) was to be deposited on the 
gold surface to facilitate the binding of the subsequent layers. Thereafter, the 
nanoparticles were to be consecutively added to oppositely charged polyelectrolyte 
solutions, first to PEI with a molecular weight of 25 kDa and then to double stranded 
21-mer siRNA. Finally, PEI was to complete the shell as a last layer. 
 
 
Scheme 1: Flowchart illustrating the LbL deposition applied to AuNPs. After each coating 
step, AuNPs were purified by centrifugation as indicated and resuspended in unbuffered 10 
mM NaCl. 
 
The major challenge involved identifying the appropriate parameters such that the 
coating and purification of AuNPs were possible. Although various polyelectrolytes 
have been applied for LbL deposition onto nanoparticles, siRNA was not expected to 
easily wrap around small AuNPs because it is a stiff, rod-like molecule [35]. In order 
to obtain well-defined particles onto which the polyelectrolyte can be adsorbed with 
high yield and to avoid interparticle bridging and flocculation, it was important to 
choose the appropriate polyelectrolyte concentration and ionic strength [25-27, 36]. 
More specifically, smaller particles need a higher salt concentration to overcome the 
repulsive forces and to wrap the polymer around themselves. However, a high ionic 
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strength may cause aggregation of gold nanoparticles [37]. The optimal 
concentrations of PEI (as determined in chapter 3, Figure 6 and 7) and siRNA during 
coating were determined to be 1.0 mg/ml and 2.0 µM, respectively (Figure 1). 
 
 
Figure 1: Determination of the optimal siRNA concentration for the LbL coating of purified 
PEI-AuNPs. (A) the hydrodynamic diameter (white columns) and the polydispersity index 
(rhombs) of siRNA/PEI-AuNPs before (crude) and after purification (purified) were 
determined along with the corresponding zeta potential (B). The values represent the mean ± 
standard deviation of three sub-runs of one sample. The optimal concentration of siRNA was 
determined to be 2.0 µM. It was chosen according to the following parameters: (1) 
hydrodynamic diameter and polydispersity index as low as possible, (2) no agglomeration or 
increase in the hydrodynamic diameter during the purification, and (3) a high value for the 
zeta potential before and after purification. 
 
A final concentration of 10 mM NaCl proved to be suitable for maintaining a small 
hydrodynamic diameter and low polydispersity index of AuNPs during all coating and 
purification steps (see Figure 11, chapter 3, exemplified for the resuspension of PEI-
AuNPs after the second purification step). After each coating step, unbound 
polyelectrolyte was removed by centrifugation in order to avoid formation of nano-
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aggregates between free PEI and free siRNA, which would give rise to different, co-
existing particle species. Two or three purification steps were necessary after coating 
with siRNA or PEI to ensure that only a minimal amount of polyelectrolyte was 
detectable in the supernatant (Table 1).  
 
Table 1: The initial concentration of the polyelectrolytes for LbL assembly and the 
concentration of the respective polyelectrolytes in the discarded supernatant after 
purification. 
Layer 
Initial polyelectrolyte 
concentration 
Purification step 
Polyelectrolyte 
concentration in 
supernatant 
PEI 1.0 mg/ml 1 0.7312 mg/ml 
  2 0.0138 mg/ml 
  3 0.0005 mg/ml 
siRNA 2.0 µM 1 1.157 µM 
  2 0.019 µM 
 
The optimal parameters were applied to assemble the LbL particles with PEI and 
siRNA, and the successful polyelectrolyte deposition was monitored by dynamic light 
scattering (DLS), zeta potential measurements, UV-vis absorbance spectra and 
TEM. Figure 2A details the change in the hydrodynamic diameter, including the 
polydispersity index as determined by DLS. The size of AuNPs increased during 
coating from 18.5 ± 0.2 nm (MUA-AuNPs) to 26.8 ± 0.3 nm (PEI/siRNA/PEI-AuNPs). 
Additionally, a reversal of the ξ-potential after completion of each layer signified the 
deposition of each polyelectrolyte (Figure 2B). After purification, the ξ-potential 
slightly decreased due to removal of unbound polyelectrolyte. The red shift of the 
surface plasmon band of gold nanoparticles was used to distinguish between 
polymer adsorption onto the AuNP surface and interparticulate bridging and 
aggregation [25-27, 36]. The UV-vis spectra in Figure 2C revealed that the AuNPs 
predominantly remained disaggregated after coating and that only low interparticulate 
bridging could have occurred, as the maximum of the plasmon peak shifted between 
1 and 2 nm with consecutive layer deposition (Figure 2D). This was confirmed by 
statistical evaluation of electron micrographs (Figure 2E) that were made after each 
layer during LbL assembly (500 AuNPs were measured for each type of AuNPs, for 
micrographs see Figure 3). The majority of AuNPs remained as single particles 
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during the LbL assembly. Although an increasing amount of AuNP doublets (2 Au 
cores per aggregate) appeared with consecutive layer build-up, it never surpassed a 
fraction larger than 7%. 
  
 
Figure 2: Characterization of AuNPs during LbL build-up by different methods. (A) The effect 
of the subsequent coating steps on the hydrodynamic diameter (white columns) and the 
polydispersity index (rhombs) of AuNPs before (crude) and after purification (purified) are 
shown as well as (B) the corresponding zeta potential. The values represent the mean ± 
standard deviation of three sub-runs of sample. One representative experiment of five 
independent ones is shown. (C) UV-vis spectra of AuNPs from top to bottom: MUA-AuNPs, 
PEI-AuNPs, siRNA/PEI-AuNPs, PEI/siRNA/PEI-AuNPs and (D) the corresponding maximum 
position of the plasmon resonance peak. (E) Quantitative evaluation of TEM images (see 
Figure 4). 500 AuNPs were counted and the fraction of n Au-cores per aggregate was 
determined.  The number of Au cores was n=1 (white columns) or n=2 (black columns). 
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Also worth noting is the number of siRNA molecules per AuNP, which was calculated 
to be around 780 siRNA molecules per siRNA/PEI-AuNP and PEI/siRNA/PEI-AuNP. 
This number is in a similar range as the one for AuNPs that were functionalized with 
15-mer oligonucleotides via a thiol linker [38]. Overall, these results demonstrated 
that by selecting the experimental parameters accordingly during LbL assembly, 
most AuNPs remained single and maintained their small and uniform size. 
 
 
Figure 3: Transmission electron micrographs of colloidal AuNPs after the coating steps. Only 
the cores of AuNPs are visible, as the coating has inherently low contrast under the 
preparation and imaging conditions chosen. The bar indicates 200 nm. 
 
Random, self-assembled aggregates of PEI and nucleic acids may suffer from 
severe aggregation when subjected to the high ionic strength of biological fluids [8, 
39]. As a result of aggregation, the initial size of these complexes may increase to 
several micrometers [39]. This feature would make the fabrication of LbL coated 
nanoparticles tedious and would render their application in cell culture pointless. 
Hence, AuNPs were exposed to cell culture medium containing fetal bovine serum, 
and the hydrodynamic diameter and the ξ-potential were monitored (Figure 4A and 
B). Irrespective of the type of the outer layer (PEI or siRNA), the hydrodynamic 
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diameter of AuNPs increased only by a factor of 2.1 to 2.5. This increase in diameter 
is also reflected in the corresponding UV-vis spectra shown in Figure 4C (maximum 
of the plasmon peak was as follows: PEI-AuNPs: 530 nm, siRNA/PEI-AuNPs: 532 
nm, PEI/siRNA/PEI-AuNPs: 536 nm). 
 
Figure 4: Characterization of AuNPs in different media. AuNPs were diluted in Millipore 
water ( ) or serum-containing culture medium ( ) and (A) the particle size as well as (B) the 
zeta potential were measured. The values represent the mean ± standard deviation of three 
sub-runs of one sample. One representative experiment of three independent ones is shown. 
The UV-vis spectra of AuNPs after dilution in serum-containing (C) or serum-free culture 
medium (D). The spectra from top to bottom are as follows: PEI-AuNPs, siRNA/PEI-AuNPS, 
PEI/siRNA/PEI-AuNPs. 
 
The extent of growth in diameter can most likely be attributed to the adsorption of 
proteins on the surface, as has already shown for unmodified and other 
oligonucleotide modified AuNPs [16, 40]. Interestingly, the ξ-potential of all particle 
types was negative after incubation with serum containing culture medium (Figure 
4B). More specifically, the negative ξ-potential of siRNA/PEI-AuNPs became more 
positive, while PEI- and PEI/siRNA/PEI-AuNPs showed a charge reversal. After 
incubation in serum-free culture medium, the particle size increased by 7 to 10 fold 
(data not shown), and the UV-vis spectra in Figure 4D show that the individuality of 
AuNPs was lost (maximum of the plasmon peak was as follows: PEI-AuNPs: 575 nm, 
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siRNA/PEI-AuNPs: 580 nm, PEI/siRNA/PEI-AuNPs: 582 nm), which corroborates the 
hypothesis that serum proteins are necessary for stabilization of the nanoparticles. 
The positive surface charge of self-assembled complexes of PEI and nucleic acids 
guarantees the cellular entry of negatively charged nucleic acids that are usually not 
incorporated by cells [39]. Therefore, it was not evident that LbL-assembled 
nanoparticles with an overall negative surface charge, even with PEI as a surface 
layer, were taken up by cells. To obtain quantitative data for the number of AuNPs 
per cell, CHO-K1 cells were incubated for 6 hours with siRNA/PEI- or PEI/siRNA/PEI-
AuNPs in serum-containing culture medium and, subsequently, the Au3+ content of 
the cell digest was determined by inductively coupled plasma spectroscopy (ICP-
OES).  
 
Figure 5: The cellular uptake of AuNPs. The number of AuNPs per cell as determined by 
ICP-OES and cell counting  after 6 hours of incubation in serum containing culture medium 
as a function of surface modification. The initial concentration of AuNPs in the culture 
medium was 0.32 and 0.30 nM for siRNA/PEI- and PEI/siRNA/PEI-AuNPs, respectively. For 
each measurement cells from 3 culture flasks (75 cm2 each) were pooled to obtain values 
within the calibration range, bars are averages of two measurements of one representative 
experiment of two independent ones. 
 
Both types of particles were successfully taken up by CHO-K1 cells and the average 
amount of AuNPs per cell strongly depended on the type of the top layer. CHO-K1 
cells internalized more siRNA/PEI-AuNPs (estimated number: 2.0 x 105 per cell) in 
relation to PEI/siRNA/PEI-AuNPs (estimated number: 5.6 x 104 per cell) (Figure 5). 
This difference correlated well with the electron micrographs of sections of CHO-K1 
cells (Figures 6 and 7).  
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Figure 6: Transmission electron micrograph of a 70 nm ultrathin section of a CHO-K1 cell 
that was incubated with siRNA/PEI-AuNPs for 6 hours in serum-containing culture medium. 
 
Figure 7: Transmission electron micrograph of a 70 nm ultrathin section of a CHO-K1 cell 
that was incubated with PEI/siRNA/PEI-AuNPs for 6 hours in serum-containing culture 
medium. Some PEI/siRNA/PEI-AuNPs are not taken up by CHO-K1 cells and stick to the cell 
surface. 
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However, it must be noted that no distinction between AuNPs that entered the cells 
and those stuck on the outside on the cell membrane was made in this method. 
Transmission electron micrographs of CHO-K1 cells (Figures 6 and 7) illustrate that 
this consideration must be taken into account for PEI/siRNA/PEI-AuNPs, but not for 
siRNA/PEI-AuNPs. Therefore, the ICP-OES and the transmission electron 
micrographs together allow for the conclusion that the number of siRNA/PEI-AuNPs 
per cell is significantly higher as compared to PEI/siRNA/PEI-AuNPs. In comparison 
to citrate stabilized AuNPs, the amount of siRNA/PEI- and PEI/siRNA/PEI-AuNPs per 
cell was much higher [16], while the number of siRNA/PEI-AuNPs per cell was similar 
to other DNA-modified AuNPs [40]. 
The significant difference in cellular uptake of AuNPs that are of nearly similar size, 
but possess different outer layers suggests that surface properties may strongly 
affect interactions with cells. Their homogeneous size distribution renders the AuNPs 
highly favorable for this investigation, because it has been shown that the size of 
AuNPs strongly influences the number of AuNPs that are taken up per cell [16]. 
Hence, we can conclude the differences in the cellular of siRNA/PEI- and 
PEI/siRNA/PEI-AuNPs are due to differences in surface properties and not size (due 
to a broad size distribution). Additionally, we show electron micrographs of sectioned 
CHO-K1 cells that help to elucidate the intracellular fate of the AuNPs. The 
micrographs in Figure 8 illustrate that the AuNPs were predominantly trapped within 
endocytotic vesicles after 6 hours of incubation, and no particles were detected in the 
nucleus. Figure 8A-C shows a typical image after incubation with siRNA/PEI-AuNPs. 
Each endocytotic vesicle contained several nanoparticles. Within one vesicle, some 
particles were still single or have formed a doublet or a triplet (3 Au cores per 
aggregate), but most have aggregated to larger clusters. In contrast, after incubation 
with PEI/siRNA/PEI-AuNPs (Figure 8D-F), less vesicles per cell containing AuNPs 
were counted, and the number of AuNPs per vesicle was also lower as compared to 
siRNA/PEI-coated particles. It was remarkable that, inside of the endocytotic 
vesicles, the particles remained either single or formed at most doublets. Some 
PEI/siRNA/PEI-AuNPs, but not siRNA/PEI-AuNPs, were also detected in caveolae-
like structures (Figure 8D). It will be of great interest to investigate the intracellular 
fate of PEI/siRNA/PEI-AuNPs and siRNA/PEI-AuNPs that are produced in different 
size ranges in future experiments. 
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Figure 8: The cellular uptake of (A-C) siRNA/PEI-AuNPs and (D-F)PEI/siRNA/PEI-AuNPs 
into CHO-K1 cells as evaluated by TEM. The bar indicates 0.13 µm in D, and 0.20 µm in all 
other images. 
 
Having demonstrated that the AuNPs are uniform in size and surface charge and 
homogeneous in distribution, we wanted to determine their intracellular fate as siRNA 
carriers. In particular, it was of great importance to provide evidence of activity of the 
siRNA inside the cells. This capability was tested in CHO-K1 cells stably expressing 
enhanced green fluorescent protein (CHO-K1/EGFP). To test the specificity of the 
knock-down, two different types of siRNA were applied for LbL-nanoparticle 
formation: siRNA against EGFP and a non-targeted siRNA sequence as control. A 
dose-dependent knock-down was measured for PEI/siRNA/PEI-AuNPs, and the 
cellular EGFP production was reduced to about 28% (Figure 9A). Control 
formulations with non-targeted siRNA revealed that gene silencing was highly 
specific. The cell viability of CHO-K1/EGFP cells was not seriously influenced by the 
addition of AuNPs (Figure 9B), as it only slightly decreased to 93.4 ± 1.1% and 95.0 ± 
0.8%, respectively, at the highest AuNP concentration.  
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Figure 9: (A) Gene silencing of EGFP in CHO-K1 cells stably expressing EGFP and (B) 
relative cell viability after addition of PEI/siRNA/PEI-AuNPs at various initial concentrations. 
For LbL assembly of nanoparticles either siRNA against EGFP ( ) was used or a non-
targeted siRNA control ( ). The values represent the mean ± standard deviation (n=3). One 
representative experiment of three independent ones is shown. 
 
When siRNA was used as the top layer, no silencing efficacy was detected (Figure 
10). Possible reasons may include degradation of unprotected siRNA on the surface 
of the nanoparticles, inadequate endosomal escape of nanoparticles due to a lower 
amount of the transfection reagent per particle or even the agglomeration of the 
AuNPs during cellular uptake. 
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Figure 10: Gene silencing of EGFP in CHO-K1 cells stably expressing EGFP after addition 
of siRNA/PEI-AuNPs at various initial concentrations. For LbL assembly of nanoparticles, 
either siRNA against EGFP ( ) was used or a non-targeted siRNA control ( ).The values 
represent the mean ± standard deviation (n=3). One representative experiment of two 
independent ones is shown 
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We also compared the parameters of siRNA delivery using PEI/siRNA/PEI-AuNPs 
with the ones using random-assembled siRNA/PEI-agglomerates. For the same 
amount of cells, the latter process usually requires 100 nM siRNA in combination with 
3.8 to 5.1 µg PEI to achieve a similar knock-down in gene expression [34]. In this 
study, both the siRNA and PEI concentration were higher (siRNA: 1.2 to 2.9 fold; 
PEI: 12 to 16 fold). The higher siRNA concentration may most likely be necessary 
because LbL-coated AuNPs are very stable and, hence, the release of siRNA inside 
cells may occur only to a low extent. Therefore, in future experiments, the fabrication 
of LbL nanoparticles with polymers that are biodegradable inside cells will most likely 
allow for improved release of siRNA and, subsequently, a lower AuNP concentration 
will be sufficient to achieve the same effect. It was remarkable that PEI/siRNA/PEI-
AuNPs showed no serious toxicity in cell culture despite a PEI concentration that 
typically induces devastating cellular toxicity. One possible reason may be the 
removal of free polymer, as this is usually associated with the high toxicity of PEI [41-
43].  
 
Conclusion 
In summary, we were the first to successfully show the LbL assembly of the 
oppositely charged polyelectrolytes siRNA and PEI on AuNPs. This technique offers 
a unique opportunity to fabricate well-defined and homogenously distributed nano-
carriers for siRNA delivery. In future experiments, these LbL-coated nanoparticles will 
provide an excellent tool to study how the size and the surface properties influence 
the portal of entry into cells and direct distinct particles to the correct site of activity. 
The obtained information will help to detect existing limitations and to design new 
materials for siRNA delivery. 
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Abstract 
Nanoparticles have emerged as promising candidates for nucleic acid delivery. 
However, most nanoparticle preparations suffer from poor characterization of the size 
distribution and a huge polydispersity in the particle collective. Unfortunately, the 
uptake of molecules into cells is complex and highly regulated, and the 
physicochemical properties of the nanoparticles strongly affect their cellular uptake. 
Here, we investigated how size influences the cellular uptake of LbL-coated gold 
nanoparticles (LbL-coated AuNPs) for nucleic acid delivery, and the amount of cargo 
molecules per cell. We also investigated the relationship between the amount of 
active substance taken up by the cells and the size of the AuNPs. Our study showed 
that the smaller AuNPs were more successfully taken up by the cells than larger 
particles. Interestingly, the amount of active substance was higher for the larger 
particles.  In other words, fewer large particles are required to deliver a similar 
amount of active molecules per cell. In summary, this study will assist in the future 
design of nano-structures for nucleic acid delivery for biomedical applications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5  Size Dependent Uptake of LbL AuNPs 
- 123 - 
1. Introduction 
Recent years have seen tremendous progress in the design and study of nano-
materials geared towards biomedical applications.  Many of these advances have 
had the intention of manipulating or probing structures and processes in a biological 
context. Due to their small size and the possibility of easily modifying their surface, 
nanoparticles offer unique advantages in imaging [1, 2], bio-sensing [3, 4], and drug 
and gene delivery [5-7]. The “nano-bio” interface comprises many physicochemical 
interactions between nanoparticles and biological systems, but we have just begun to 
understand the forces and components that shape these interactions, and are still far 
from having a complete picture. However, the safe and effective design of nano-
materials for biomedical applications requires a clear understanding of these 
interactions. 
A major bottleneck for nanoparticles delivering any kind of cargo molecules into cells 
is their cellular uptake. It is known that the size, shape, chemical composition, and 
surface properties of nanoparticles strongly affect the nature and extent of the 
interaction with mammalian cells, thereby determining their access into cells [8-10]. 
In addition, other properties, such as the effective surface charge, particle 
aggregation, and the state of dispersion (which are characterized by the surrounding 
media and include ionic strength, pH, and even the presence of large organic 
molecules such as proteins) also play an important role in this process [11, 12]. For 
example, for every particle species that is capable of cellular entry, an optimal radius 
exists, which accelerates membrane wrapping at the cell surface and promotes 
particle uptake. Any deviation from this optimal value strongly reduces cellular 
uptake. For receptor-mediated endocytosis, various models have determined the 
optimal nanoparticle radius to be in the range of 15 – 30 nm [14-16]. However, most 
nanoparticle preparations suffer from a poor characterization of the size distribution 
and a huge polydispersity of the particle collective [17, 18]. This fact leads to 
inconsistent experimental results concerning the optimal particle diameter for cellular 
uptake and illustrates the considerable gap in the current understanding of such 
“nano-bio” interactions. 
Gold nanoparticles (AuNPs) have the potential to overcome these limitations 
because they can be prepared with a high degree of monodispersity and on a 
relatively large scale using the methodology established by Frens [19]. The resulting 
AuNPs have unique optical properties dependent on their size and shape, can be 
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easily modified with functional groups to anchor additional moieties such as ligands, 
nucleic acids, or proteins, and show a very good biocompatibility [20-23]. Chan and 
coworkers investigated how the size of citrate-stabilized AuNPs (14, 30, 50, 74 and 
100 nm) affects the uptake into HeLa cells [24]. The maximum uptake occurred at a 
particle size of 50 nm and decreased with smaller and larger particle sizes, which is 
in good agreement with the theoretical models. The same group also investigated the 
cellular uptake of AuNPs coated with the ligand transferrin, with the intention of 
entering the cells via receptor-mediated endcytosis [25]. 50 nm particles were taken 
up at a higher rate than 14 nm particles because for the smaller particles at least 6 
had to cluster together before uptake, while for the membrane wrapping of the 50 nm 
particles a single AuNP was sufficient. In another study, not only the uptake of 
AuNPs (ranging from 2 – 100 nm) coated with the antibody Herceptin was highly 
dependent on the size with the most efficient uptake occurring between 25 and 50 
nm, but also the cellular response [26].  
Recently, we demonstrated the manufacture of well-defined and homogenously 
distributed nano-carriers for nucleic acid delivery by depositing two oppositely 
charged polyelectrolytes on the surface of AuNPs [27]. We coated AuNPs in a Layer-
by-Layer (LbL) approach, starting with positively charged poly(ethylene imine) (PEI) 
with a Mw of 25 kDa, then deposited a negatively charged nucleic acid (21 bp), and 
completed the coating with PEI as a last layer. The nanoparticles were small (~25 
nm) and delivered nucleic acid into cells that showed a strong biological effect. The 
main question that arises from the context above is “What is the optimal size for the 
cellular uptake of LbL-coated AuNPs?” Additionally, it would be of great importance 
to know which biological significance such a size-dependent cellular uptake would 
recover because for most preparations delivering nucleic acids into cells not the 
number of particles internalized is the most important factor, but the amount of active 
substance taken up. And this latter factor also strongly correlates with the size of the 
AuNPs, meaning that larger LbL-coated AuNPs have a higher loading capacity for 
nucleic acid. The results from this study will provide a better understanding in 
elucidating the relationship how the size of LbL-coated AuNPs affects the cellular 
uptake. 
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 2. Experimental 
2.1. Materials 
Commercially available gold nanoparticles of different sizes (20, 30, 50, and 80 nm) 
were purchased from BBinternational (Cardiff, England). Poly(ethylene imine) (PEI) 
Mw = 25,000 g/mol-1, 11- Mercaptoundecanoic acid (11-MUA), D-MEM medium, and 
Nutrient Mixture F-12 [HAM] (HAM F-12) were purchased from Sigma-Aldrich 
Chemical Company (Steinheim, Germany). 21 base pair DNA was synthesized by 
Eurofins MWG Operon (sense strand: 5´-ATGAACTTCAGGGTCAGCTTGC-3´and 
antisense strand: 5´-GCAAGCTGACCCTGAAGTTCAT-3´). Picryl sulfonic acid 
solution was purchased from Fluka (Steinheim, Germany). Sodium chloride, sodium 
hydroxide, nitric acid, hydrochloric acid, and absolute ethanol were purchased from 
Merck (Darmstadt, Germany). DyLight 649 NHS-Ester was purchased from Thermo 
scientific (Rockford, U.S.A.). Chinese hamster ovarian cell line (CHO-K1 cells) 
(ATCC No. CCL-61), human cervical carcinoma cell line (HeLa cells) (ATCC No. 
CCL-2), human breast cancer cell line (MCF-7 cells)(ATCC No. HTB-22) and human 
colorectal carcinoma cell line (HCT 116 cells) (ATCC No. CCL-247) were grown in 
75cm2 culture flasks to 90% confluency. Dulbecco's Phosphate buffer saline 1x 
(DPBS), Dulbecco´s Medium and leibovitz's L-15 medium 1x without phenol red were 
purchased from (GIBCO) Invitrogen (Germany). Fetal bovine serum (FBS) was 
purchased from Biochrom AG (Germany). The ultrafiltration units had a 3 KDa cut-off 
membrane (Nanosep 3K Omega) was purchased from (Pall Corporation, Mexico). All 
glassware was thoroughly washed with freshly prepared aqua regia (HCl: HNO3 = 
3:1) [Caution! Aqua regia is a strong acid], extensively rinsed with Millipore water 
several times and oven-dried at 150 °C for 2-3 h before use. All used solution was 
filtered through 0.22 µm membrane filter (Corning Incorporated, Corning NY 14832, 
Germany) before use. 
 
2.2. Stabilization and LbL coating of AuNPs 
The pH of different sized AuNPs was adjusted to 11 with 1N NaOH, followed by the 
addition of 11-MUA at a final concentration of 0.1 mg/ml. The stabilized particles 
were purified two times at 15,700 xg for 10 minutes, and resuspended in 1 mM NaCl. 
The coating of stabilized AuNPs with polyelectrolytes was performed as described 
previously [27]. In brief, each coating step with PEI or DNA was performed for 30 
minutes after the addition of different sizes of AuNPs to the stirring polyelectrolyte 
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solution. PEI was used at a final concentration of 1.0 mg/ml for the assembly of the 
first and third layers. DNA was added at a final concentration of 1.5 µM to purified 
PEI-AuNPs. Purification of the crude AuNPs was performed at 15,700 xg for 15 
minutes, and the purified AuNPs were resuspended in 10 mM NaCl. For cellular 
uptake studies using fluorescence activated cell sorting (FACS) analysis and 
confocal laser scanning microscopy (CLSM) experiments, different sized LbL-AuNPs 
were coated with PEI 25 KDa that was labeled with DyLight 649. PEI 25 KDa was 
labeled with DyLight 649 according to the manufacturer's protocol. The labeling 
reaction was carried out with a molar ratio of 1 dye molecule per 10 PEI molecules at 
room temperature (RT) in the dark.  The excess dye was removed by repeating 
ultrafiltration MWCO 3 KDa. 
 
2.3. Determination of excess polyelectrolyte after purification 
The amount of free polyelectrolytes (PEI and DNA) in the supernatant after 
purification was determined in order to identify the exact amount of polyelectrolyte 
adsorbed on the surfaces of different sized LbL-coated AuNPs. The amount of PEI in 
the supernatant was determined according to the method of Snyder et al. [28] that 
uses 2,4,6 Trinitrobenzenesulfonic acid (TNBS) for the detection of amines. In brief, 
25 µl of a 0.03 M TNBS solution were added to 1 ml of the supernatant containing 
PEI. After 30 minutes at room temperature, the absorbance was read at 420 nm 
using an Uvikon 941 spectrophotometer. The concentration of PEI was calculated 
using a standard calibration curve. The amount of free DNA in the supernatant was 
determined by UV measurement at 260 nm using a standard calibration curve. 
 
2.4. Characterization of the LbL-coated gold nanoparticles 
2.4.1. UV-visible spectroscopy of AuNPs 
UV-vis absorbance spectra of the AuNPs after each coating step were recorded 
using an Uvikon 941 spectrophotometer (Kontron Instruments GmbH). 
2.4.2. Size and zeta potential measurements by dynamic light scattering (DLS) 
For the determination of size and ξ-potential, the samples of AuNPs were 
thermostated to 25 0C and laser light scattering analysis was performed with an 
incident laser beam of 633 nm at a scattering angle of 1730 using the Malvern 
ZetaSizer Nano-ZS (Malvern Instruments GmbH). The ξ-potential measurements 
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were performed in disposable folded capillary cells (Malvern Instruments GmbH), 
measuring the electrophoretic mobility at 25 0C.   
2.4.3. TEM image of the gold nanoparticles 
Transmission electron micrographs (TEM) of AuNPs were taken on a Philips CM12 
microscope (FEI, Eindhoven, The Netherlands). Samples were prepared by 
depositing the colloidal gold solution onto a carbon-coated copper grid and air-dried 
before analysis. Several micrographs were taken per sample.  
2.4.4. Determination of gold nanoparticles concentration by ICP-OES 
The concentration, and consequently the number of AuNPs per volume after 
synthesis, was determined by using inductively coupled plasma-optical emission 
spectroscopy (ICP-OES). 500 µl of a sample containing AuNPs was mixed with 200 
µl freshly prepared aqua regia [Caution! Aqua regia is a strong acid] and diluted to 5 
ml with Millipore water. The Au3+ content of the solution was determined by ICP-OES 
analysis on a JY-70 PLUS (Jobin Yvon Instruments S.A.). The plasma flow was 16 
L/min argon. All standards were made with gold (III) chloride at concentrations of 0.1, 
1, 10 and 100 ppm. The measured concentration of Au3+ was divided by the number 
of gold atoms per particle to obtain the concentration of AuNPs in solution [24]. 
2.4.5. Stability of LbL-coated nanoparticles in cell culture medium 
The stability of AuNPs after each coating step was investigated in serum free and 
serum containing culture medium (leibovitz's). The change in UV-vis spectra, 
hydrodynamic diameter, and ξ-potential were monitored. 
 
2.5. Determination the protein adsorption using 2D SDS-PAGE 
The proteins adsorbed to the surface of AuNPs were analyzed after desorption from 
the surface using two-dimensional sodium dodecylsulfate polyacrylamide gel 
electrophoresis (2D SDS-PAGE) [29, 30]. First, the LbL-coated AuNPs were 
incubated in culture medium containing 10% fetal calf serum for 5 minutes at 37 0C, 
then the particles were purified 5 times to remove free, unbound proteins by repeated 
centrifugation. Afterwards, the proteins were desorped from the nanoparticles surface 
by incubation with a solution of sodium dodecylsulafte (SDS) and dithiothreitol (DTT) 
for 5 minutes at 95 0C. The proteins were analyzed by SDS-PAGE using PROTEAN 
IEF cell (U.S.A). Electrophoresis was run overnight at 500 V. Gels were stained by 
silver staining as described by Shevchenko et al. [31]. 
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2.6. Cell culture and cellular uptake studies 
Cell culture 
Cell lines were cultivated in 75 cm2 culture flasks at 37°C in a 5% CO2 humidified 
environment. CHO-K1 cells were grown in culture medium consisting of HAM F-12. 
HeLa cells were maintained in Dulbecco´s Medium. MCF-7 cells were grown in 
Minimum Essential Medium (MEM). HCT 116 cells were maintained in D-MEM 
medium. All cell culture medium were supplemented with 10% FBS.  
2.6.1. Cellular uptake kinetics using Flow Cytometry 
Different cell lines were seeded in a 24-well plate at an initial density of 80,000 cells 
per well for HeLa and CHO-K1 cells and 120,000 cells per well for MCF-7 and HCT 
116 cells one day before the experiments. The culture medium was then removed, 
the cells were washed with PBS, and different volumes of purified LbL-coated AuNPs 
were added to the cells in leibovitz’s containing 5% serum. Five hours after 
incubation, the medium (which contained AuNPs that were not taken up by cells) was 
removed and the cells were prepared for flow cytometry analysis as described 
previously [32]. In brief, cells were washed with PBS and detached using trypsin for 5 
min. Thereafter, the reaction was stopped with serum-containing medium and the 
cells were isolated by centrifugation for 5 min at 200 xg. Finally, the cells were 
washed with PBS (4 °C) twice, and resuspended in cold PBS for the measurements. 
Untreated cells were used to determine the autofluorescence of cells. Measurements 
were taken on a FACS Calibur (Becton Dickinson, Germany) using CellQuest Pro 
software (Becton Dickinson, Germany) and evaluated by WinMDI 2.8 software 
(©1993–2000 Joseph Trotter). DyLight fluorescence was excited at 646 nm and 
detected in the channel FL4 (661/16) band-pass filter. The percentage of cells that 
had internalized AuNPs was determined by the number of DyLight positive cells, and 
mean fluorescence intensity (MFI) of those cells that had taken up AuNPs served an 
indirect measure for the number of internalized nanoparticles. All values were 
normalized to cells that received culture medium only, without particles. 
2.6.2. Cellular uptake of LbL-coated AuNPs using ICP-OES 
CHO-K1 Cells were incubated with leibovitz’s with 5% serum containing LbL-coated 
AuNPs for 6 hours. Thereafter, the cells in three flasks were washed two times with 
PBS, detached from the flask via trypsinization, pelleted, and washed again with 
PBS. For the determination of the Au3+ content by ICP-OES the cell pellet was air 
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dried, dissolved in 500 µl of freshly prepared aqua regia [Caution! Aqua regia is a 
strong acid] and diluted to 5 ml with Millipore water. ICP-OES analysis of the samples 
was performed on a JY-70 PLUS (Jobin Yvon Instruments S.A.) with a plasma flow of 
16 L/min argon. All standards were made with gold (III) chloride at a concentration of 
0.1, 1, 10 and 100 ppm. The measured number of Au3+ was used to calculate the 
number of AuNPs as described by Cumberland et al. [33] and related to the total 
number of cells. The number of total cells was determined by counting the cells of 
one 75cm2 culture flasks in a Neubauer Chamber. The samples for cell counting 
were incubated with AuNPs in the same way as samples for ICP-OES 
measurements. Cell samples treated as described above but without addition of 
AuNPs, were used as controls for background subtraction. 
2.6.3. Intracellular trafficking of LbL-coated AuNPs- confocal laser scanning 
microscopy (CLSM) 
A Zeiss Axiovert 200 M microscope coupled to a Zeiss LSM 510 scanning device 
(Carl Zeiss Co. Ltd., Germany) was used for CLSM experiments. The inverted 
microscope was equipped with a Plan-Apochromat 63× objective. CHO-K1 cells were 
plated in an 8-well Lab-Tek™ Chambered Coverglass (Nunc GmbH & Co. KG, 
Wiesbaden, Germany) at an initial density of 20,000 cells per chamber. After 24 h, 
the culture medium was removed and the cells were washed with PBS. Afterwards, 
AuNPs that were fabricated with DyLight 649 labeled PEI were added to the cells, 
and imaging commenced after 5 h in each well at 37 °C. DyLight-labeled PEI was 
excited at 646 nm and the fluoresecence was recorded with a 670 longpass filter. 
The pinhole was set to one Airy Unit. Approximately 20 images were evaluated for 
each condition. 
2.6.4. Cytotoxicity assay 
Cytotoxicity of LbL-coated AuNPs was determined by an MTT (3-(4,5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay in CHO-K1 cells. This 
assay is based on the ability of living cells to reduce a water soluble yellow dye, MTT, 
to a purple colored water-insoluble formazan product using a mitochondrial enzyme 
called succinate dehydrogenase. Cells were grown in 96-well plates at an initial 
density of 14,000 cells per well for 24 h to approximately 100% confluence. For the 
experiments, the medium was removed and the cells were washed with PBS. AuNPs 
at different concentrations in 100 µl media were added to the wells.  After 5 h of 
incubation, a solution of MTT (0.626 mg/ml in PBS) was added to cells followed by 
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further incubation for 4 h at 37 °C. Thereafter, the medium was carefully removed 
and the cells were rinsed with PBS. The formazan crystals formed were dissolved 
using a 10 % solution of sodium dodecyl sulfate (SDS) in PBS (100 µl/ well). After 16 
h of incubation in the dark at RT, the samples were measured by a plate reader 
(Shimadzu, Duisburg, Germany) at 550 nm.  
 
3. Results and discussion 
In this study, we used commercially available AuNPs with sizes of 20, 30, 50 and 80 
nm. All particles were coated as described, starting with a first layer of PEI, followed 
by a layer of DNA and a final layer of PEI [27]. PEI was used because it is known to 
be highly efficient in transfecting cells, and the DNA with a random sequence of 21 
bp was used as model for different types of nucleic acids. After each coating step, it 
was necessary to purify the coated particles from free, unbound polyelectrolytes to 
avoid the formation of inter-polyelectrolyte complexes between DNA and PEI. The 
successful polyelectrolyte deposition was monitored by dynamic light scattering 
(DLS), zeta potential measurements, UV-vis absorbance spectroscopy and 
transmission electron microscopy (TEM). Figure 1 A shows the hydrodynamic 
diameter of the AuNPs of different sizes after the last coating step, including the 
polydispersity index as determined by DLS. The size of AuNPs ranged from 32.0 ± 
0.2 nm to 84.8 ± 0.1 nm, and all LbL-coated particles showed a positive zeta 
potential (Figure 1 B). The surface plasmon resonance (SPR) peak of the UV-vis 
spectra of the AuNPs shifted about 4 - 6 nm during the coating process, which is in 
good agreement with the literature (Figure 1 C) [34-36]. Additionally, TEM 
micrographs revealed that the majority of LbL-coated AuNPs remained single 
particles during the LbL assembly without any sign of aggregation, and the 
nanoparticles were spherical (Figure 1 D). 
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Figure 1: Characterization of the AuNPs of different sizes after coating with PEI, DNA, and 
PEI by different methods. (A) The hydrodynamic diameter (white columns) and the 
polydispersity index (rhombs) of LbL-coated AuNPs are shown with (B) the corresponding 
zeta potential. The values represent the mean ± standard deviation of three sub-runs of one 
sample. One representative experiment of three independent ones is shown. (C) The 
maximum position of the SPR peak of UV-vis spectra of AuNPs is shown before (black 
rhombs) and after (grey circles) the coating process. (D) Transmission electron micrographs 
of colloidal AuNPs after the coating steps. Only the cores of AuNPs are visible, as the 
coating has inherently low contrast with the preparation and imaging conditions chosen. The 
bar indicates 600 nm. 
 
Another important consideration for the evaluation of the cellular uptake of LbL-
coated AuNPs is their stability in cell culture medium. If the particles are susceptible 
to environmentally induced aggregation, the tedious manufacture and the 
investigation of different sizes of AuNPs would be useless. It was for this reason that 
AuNPs were exposed to cell culture medium containing 10% fetal calf serum, and the 
hydrodynamic diameter and the zeta potential were monitored (Figure 2 A and B). 
The diameter of the LbL-coated AuNPs increased by approximately 2.6 fold for each 
particle size, and all particles showed a reversal of the zeta potential. This extent of 
20 
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the growth in diameter can most likely be attributed to the adsorption of proteins on 
the surface, as already shown for unmodified and other oligonucleotide-modified 
AuNPs [24, 37]. At the same time, the polydispersity index did not significantly 
change, which indicates that the AuNPs only grew due to protein adsorption but not 
due to particle aggregation. In contrast, after incubation in culture medium without 
serum, the size of the particles increased by about 5 to 8  fold which is most likely 
due to the formation of larger aggregates (data not shown). So far, the adsorption of 
proteins to the surface of AuNPs has only been indirectly confirmed by such data as 
size or FTIR measurements [24, 38, 39]. In contrast, our intention was to provide 
direct evidence by analyzing the proteins after desorption from the surface. To this 
end, particles were incubated in culture medium containing 10% fetal calf serum and 
then were purified 5 times to remove  the free, unbound proteins. After desorption of 
the proteins from the particle surface, they were analyzed by 2D SDS-PAGE. The 
proteins were first separated by their isoelectric point, and in the second dimension 
by their molecular weight [29, 30, 40]. Figure 2 C shows the analysis of pure fetal calf 
serum and Figure 2 D illustrates the proteins that were desorbed from LbL-coated 
AuNPs with a core of 20 nm (only qualitative analysis). The gels show that a 
significant amount of different serum proteins adsorbed to the surface of LbL-coated 
particles. Additionally, the red boxes in Figure 2 D display some low abundace 
proteins that are not visible in the gel of pure fetal calf serum (Figure 2 C), but seem 
to be enriched on the particle surface. This interaction between the nanoparticles and 
the proteins seems to be of great importance, since it alters not only the surface 
properties and charge, but also the resistance to particle aggregation. 
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Figure 2: Investigation of the stability of LbL-coated AuNPs in culture medium containing 
fetal calf serum. AuNPs were diluted in Millipore water or serum-containing culture medium 
and (A) the particle size (black and white bars, respectively), the polydispersity index (black 
and white circles, respectively), and (B) the zeta potential were measured. The values 
represent the mean ± standard deviation of three sub-runs of one sample. Additionally, 2D 
SDS-PAGE was performed with (C) pure fetal calf serum as a control and (D) the proteins 
that were desorbed from LbL-coated AuNPs. The gels can only be compared qualitatively. 
 
Since AuNPs did not aggregate after incubation in serum containing culture medium, 
the cellular uptake was investigated by two different methods. The extent of particle 
uptake was quantified either by fluorescence-activated cell sorting (FACS) using LbL-
coated AuNPs that were fabricated with fluorescently-labeled (DyLight 649) PEI as a 
last layer or by inductively coupled plasma spectroscopy (ICP-OES) using unlabeled, 
LbL-coated AuNPs. Because the FACS method allows for the determination of the 
amount of fluorescently-labeled PEI inside cells, but not for the amount of AuNPs per 
cell, it was first necessary to measure the amount of labeled PEI that was adsorbed 
on the AuNP surface on the different sizes of AuNPs. As expected, the PEI amount, 
as well as the number of DNA molecules, increased with the size of the AuNPs 
(Table 1). Figure 3 shows that this increase in the adsorption of polyelectrolytes 
depending on the size runs exponentially, with the amount of PEI per AuNP 
increasing up to about 38 fold, and amount of DNA per AuNP up to about 49 fold, 
using the AuNPs with a core ranging from 20 – 80 nm. 
 
 
 
C D 
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Table 1: Number of DNA and PEI (in the last layer) molecules per AuNP 
AuNP Core [nm] DNA molecules / AuNP PEI last layer [fg] / AuNP
20 2.2E+02 1.0
30 5.6E+02 2.1
50 3.1E+03 10.0
80 1.1E+04 38.2
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Figure 3: Exponential increase of the amount of PEI (grey circles) and DNA (black rhombs) 
depending on the size of the AuNP core. 
 
The importance of this information becomes even more evident after reviewing the 
results from the cellular uptake measured by FACS analysis. First of all, over 99% of 
all CHO-K1 cells had taken up fluorescently-labeled particles independently of the 
particle size or concentration. The histogram in Figure 4 gives an example of the 
FACS analysis and shows that the cells treated with LbL-coated AuNPs shifted to 
much higher fluorescence values compared to control cells. 
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Figure 4: Example of a histogram from the FACS analysis. The black curve is from the 
control cells, and the red curve is from the CHO-K1 cells that were incubated with 30 nm 
LbL-coated AuNPs at a concentration of 68 µM Au3+. 
 
The mean fluorescence intensity (MFI) of cells positive for particles was then used for 
the further evaluation of the data (the MFI is an indirect measure for the amount of 
PEI associated with the cells). In Figure 5 A, the MFI of CHO-K1 cells after 
incubation with the different sizes of LbL-coated AuNPs is plotted against the Au3+ 
concentration in the culture medium. The graph reveals that the larger the LbL-
coated AuNPs, the more PEI molecules are taken up by the cells. In addition, Figure 
5 B in which the MFI is referred to the amount of PEI per AuNP makes evident that 
more smaller than larger LbL-coated AuNPs are taken up by the cells. Therefore, one 
can conclude that fewer larger particles are necessary to deliver a similar amount of 
PEI or DNA molecules per cell. Most studies plot the cellular uptake versus the 
hypothetical Au3+ concentration in the culture medium that would be generated if the 
AuNPs were completely dissolved. In contrast to this, Figure 5 C shows that the MFI 
as dependent on the AuNPs in the culture medium. Here, it becomes immediately 
evident that less LbL-coated AuNPs of 80 nm (compared to 20 nm) are required to 
obtain a significantly higher fluorescent signal per cell. The same trend and similar 
results were also measured in HeLa cells (Figure 6) and in MCF-7 cells (data not 
shown).   
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Figure 5: The uptake of fluorescently labeled LbL-coated AuNPs with an AuNP core of (x) 
20, (○) 30, (□) 50 and (∆) 80 nm into CHO-K1 cells as determined by FACS analysis. The 
values represent the mean ± standard deviation of three independent samples. One 
representative experiment of four independent ones is shown.  
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Figure 6: The uptake of fluorescently labeled LbL-coated AuNPs with an AuNP core of (x) 
20, (○) 30, (□) 50 and (∆) 80 nm into HeLa cells as determined by FACS analysis. The values 
represent the mean ± standard deviation of three independent samples. One representative 
experiment of two independent ones is shown.  
 
Additionally, fluorescently labeled, LbL-coated AuNPs were observed with confocal 
laser scanning microscopy (CLSM) after incubation with CHO-K1 cells (Figure 7). 
The images also proved that the nanoparticles did not form any larger aggregates 
after incubation with cells in serum-containing culture medium. In general, there were 
no large differences visible between the AuNPs of different sizes. One could 
speculate that CHO-K1 cells endocytosed more particles of 20 nm than of the larger 
sizes, but one has to keep in mind that for a quantitative conclusion the confocal 
images have to be statistically evaluated which was not done. 
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Figure 7: Confocal images of CHO-K1 cells after 5 hours of incubation with fluorescently 
labeled, LbL-coated AuNPs with a core of (A) 20, (B) 30, (C) 50 and (D) 80 nm. Images are 
an overlay of the transmitted light and fluorescence emission. Each bar indicates 10µm. 
 
To obtain quantitative data for the number of AuNPs per cell, CHO-K1 cells were 
incubated for 6 hours with LbL-coated AuNPs in serum-containing culture medium 
and subsequently the Au3+ content of the cell digest was determined by ICP-OES. 
The particles were applied at the concentration that yielded the highest fluorescent 
signal in the FACS experiment for each particle species. Figure 8 shows the amount 
of AuNPs per cell depending on the size of the AuNP core. The ICP-OES confirmed 
the FACS experiments that many more small particles are taken up by the cells in 
comparison to larger particles. Looking at the absolute amount of particles, this 
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difference becomes even more impressing. About 13500 AuNPs with a core of 20 
nm, which corresponds to 32.0 nm after the coating with all 3 polyelectrolyte layers, 
were taken up per cell. This number significantly decreased with the size of the AuNP 
core to about 400 at an AuNP core size of 80 nm, which corresponds to 84.8 nm 
after the coating with all 3 polyelectrolyte layers. A comparison with data from 
literature indicated that the optimal particle diameter for the cellular uptake with an 
AuNP core of 25 – 50 nm can only be performed very roughly, because these studies 
do not take into account that the size of the AuNPs significantly increases after 
incubation in serum containing culture medium [24, 26]. With respect to the size of 
LbL-coated AuNPs directly after the coating process, our results are in good 
agreement with literature values. However, if considering that the protein corona 
adds a significant size to the AuNPs, it is not possible to make a comparison 
because one has to deal then with particles ranging from about 87.8 to 216.9 nm. 
 
Figure 8: The number of AuNPs per cell as determined by ICP-OES and cell counting after 6 
hours of incubation in serum containing culture medium as a function of the size of the AuNP 
core. For each measurement, cells from 3 culture flasks (75 cm2 each) were pooled to obtain 
values within the calibration range. Bars are averages of two measurements of one 
representative experiment of three independent ones performed.  
 
With these data it was now possible to calculate the amount of DNA and PEI 
molecules that were hypothetically delivered into one CHO-K1 cell depending on the 
size of LbL-coated AuNPs. It was remarkable that the overall amount of nucleic acid 
molecules that were estimated for the delivery into one cell was in the same order of 
magnitude (Table 2). 
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Table 2: Amount of DNA and PEI molecules delivered per cell as a function of the size of the 
AuNP core.  
AuNP Core [nm] DNA molecules / cell PEI [fg] / cell
20 3.0E+06 1.3E+04
30 1.7E+06 6.3E+03
50 2.7E+06 8.9E+03
80 4.3E+06 1.5E+04
 
 
In the view of a potential future in vivo application, the safety of LbL-coated AuNPs is 
of great significance. Hence, last but not least, the toxicity of the AuNPs was tested 
using an MTT assay [41]. Figure 9 impressively shows that all particles were not toxic 
to the cells at the concentrations applied during the cellular uptake experiments. 
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Figure 9: Evaluation of the toxicity of LbL-coated AuNPs with a core of (x) 20, (○) 30, (□) 50 
and (∆) 80 nm in CHO-K1 cells using a MTT assay. The values represent the mean ± 
standard deviation of eight independent samples. One representative experiment of two 
independent ones is shown 
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4. Conclusion 
In summary, in this study we investigated the effect of different sizes of LbL-coated 
AuNPs on their cellular uptake. We found that the smaller AuNPs were taken up by 
the cells to a higher extent than larger ones. Moreover, there was a positive 
correlation between the amount of active substances taken up by the cells and the 
size of LbL-coated AuNPs. The number of PEI, as well as DNA molecules, increased 
with the size of the AuNPs. Therefore, much fewer larger particles are necessary to 
deliver a similar amount of active molecules per cell. Here, we sucessfully addressed 
some important parameters to close the gap of how the physicochemical properties 
influence the cellular uptake of nanoparticles. In conclusion, this finding will assist in 
the future design of nano-structures delivering nucleic acids for biomedical 
applications. 
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Summary 
The delivery of nucleic acids to cells has gained significant attention and shown 
tremendous promise for the treatment of genetic and acquired diseases. The basic 
goal of nucleic acid delivery is to transfer therapeutic genetic material (i.e. nucleic 
acids) into the cells of an individual with the intention of expressing certain proteins 
via DNA or knocking down unwanted proteins with complementary short interfering 
RNA (siRNA). RNA interference is a fundamental mechanism for sequence specific 
gene knockdown and can be exploited by introducing siRNA into cells [1-3]. The 
delivery of siRNA into cells requires a carrier, since the siRNA is prone to enzymatic 
degradation, very large (~ 13 KDa), and too negatively charged to cross cellular 
membranes [4, 5]. Although viral vectors are highly efficient and remain the most 
popular tool for siRNA delivery, their broad use is limited by severe safety risks [6, 7]. 
Therefore, non-viral carriers have emerged as a promising alternative for siRNA 
delivery both in vitro and in vivo [8, 9]. 
Common approaches for siRNA delivery include the creation of nanoparticles using a 
surplus of either cationic polymers or lipids to compensate for the negative charge of 
the nucleic acid [10-12]. However, most of these carriers form random self-
assembled aggregates with siRNA. These aggregates are generally heterogeneous 
and poorly defined particle collectives. In addition, these nanoparticles are of various 
compositions and sizes, which are in equilibrium with free carrier molecules and free 
siRNA, as shown in Figure 1. This system makes it difficult to determine which 
species is responsible for the overall biological effects observed, and the optimization 
of existing formulations is therefore difficult to achieve. Thus, new and optimized 
strategies are required for the highly efficient delivery of siRNA to cells. 
 
 
Figure 1: The various sub-species existing in random siRNA formulation: nanoparticles of 
various composition and size, free siRNA and free carrier. 
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Therefore, the main goal of this thesis was the fabrication of homogeneously 
distributed nano-carriers with well defined size and surface properties to deliver 
siRNA into the cells. In order to achieve this goal, we utilized the Layer-by-Layer 
(LbL) technique using gold nanoparticles (AuNPs) as a template. This allowed us to 
manufacture a carrier for siRNA delivery that remained monodisperse during the 
assembly process and delivered active siRNA into cells. In order to fabricate these 
uniform nanoparticles, our strategy was to deposit siRNA as negatively charged 
polyanion and a positively charged polycation in alternative order on AuNPs via the 
LbL technique.  
In order to obtain monodisperse and uniform AuNPs suitable for coating with 
polyelectrolytes by the LbL strategy, the AuNPs were first dispersed in aqueous 
medium, and were prepared by citrate reduction of auric chloride solutions. 
Thereafter, the AuNPs were stabilized with 0.1 mg/ml 11-mercaptoundecanoic acid 
(11-MUA), yielding stabilized AuNPs suitable for the subsequent coating steps. The 
produced nanoparticles had a narrow particle size distribution and a low 
polydispersity index. Afterwards, the MUA stabilized AuNPs (MUA-AuNPs) were 
investigated at different pH values and ionic strength to identify the optimum 
conditions to produce stable monodisperse nanoparticles. These optimum conditions 
should be suitable for the complete wrapping of the polyelectrolytes around the 
nanoparticle surface, yet still allow for the sufficient stability of the nanoparticles. 
MUA-AuNPs showed a good stability over the time and in a wide range of pH values, 
which allowed for further coating at physiological pH. Moreover, MUA-AuNPs had a 
good stability in low ionic strength (1-10 mM NaCl), which is important for the 
flexibility of the polymer chain. This reduces the chain stiffness and allows the 
complete wrapping of the polymer around AuNPs. In summary, these MUA-AuNPs 
provide a good foundation for further coating by polyelectrolytes via LbL technology 
(chapter 2). 
For the successful coating of MUA-AuNPs with polyelectrolytes via the LbL technique 
for nucleic acid delivery, appropriate parameters had to be identified, including the 
polyelectrolyte type, concentration, the ionic strength of the adsorption solution and 
the particle surface properties. First, the suitability of the polycations protamine and 
poly(ethylene imine) (PEI) 25 KDa using 21 base pair DNA as a model was 
investigated. Although, the MUA-AuNPs coated well with protamine and the zeta 
potential of nanoparticles inverted to positive (reflecting successful deposition), the 
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protamine-AuNPs aggregated during the purification process. It was also difficult to 
remove free unbound protamine after coating-an important prerequisite for the 
subsequent coating step. The aggregation during purification could be attributed to 
the low molecular weight of protamine (only about 5 KDa). It was therefore 
determined that protamine is not large enough to maintain the stabilization of 
nanoparticles during purification. In contrast to protamine, PEI showed good stability 
during coating and after repeated purification steps. 1 mg/ml PEI at 1 mM NaCl and 
1.5 µM 21 bp DNA at 10 mM NaCl were successfully wrapped around AuNPs in 
alternative order via the LbL approach. The resulting PEI/DNA/PEI-AuNPs were 
small (~ 26 nm), monodisperse with narrow particle size distribution, and had a low 
polydispersity index. Interestingly, these nanoparticles did not show any sign of 
toxicity after incubation with CHO-K1 cells, which is attributed to the successful 
purification and removal of free unbound PEI from the particles. Moreover, the 
produced nanoparticles showed good stability in culture medium containing serum, 
which is most likely due to the adsorption of serum protein on the nanoparticles 
surfaces. These results corroborate the hypothesis that serum proteins are 
necessary for the nanoparticles stabilization. In addition, this finding is considered a 
prerequisite for successful cellular uptake of monodisperse nanoparticles. Both types 
of particles (DNA/PEI- and PEI/DNA/PEI-AuNPs) were taken up by the CHO-K1 cells 
and the amount of particles per cell depended on the type of the top layer. CHO-K1 
cells internalized more DNA/PEI-AuNPs (66.1 x 103 per cell) in relation to 
PEI/DNA/PEI-AuNPs (37.7 x 103 per cell). This signified that surface properties may 
strongly influence internalizations of nanoparticles with cells. Overall, the delivery of 
nucleic acid can be achieved via LbL technology using AuNPs as a template by 
selecting the experimental parameters accordingly during LbL assembly (chapter 3). 
After the appropriate parameters had successfully been investigated, the next step 
was to fabricate LbL-coated AuNPs for siRNA delivery using PEI 25 KDa as a 
polycation (chapter 4). The physicochemical characteristics of the LbL-coated 
nanoparticles allowed for the successful coating of the nanoparticles. Most AuNPs 
remained single and maintained their small and uniform size after coating. Since 
dispersity should strongly influence the cellular uptake of nanoparticles, the stability 
of nanoparticles in cell culture medium was investigated after each coating step. The 
nanoparticles showed good stability in culture medium containing serum and the zeta 
potential inverted to negative due to the adsorption of serum protein. Moreover, both 
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PEI/siRNA- and PEI/siRNA/PEI-AuNPs were taken up by the CHO-K1 cells and the 
number of siRNA/PEI-AuNPs per cell (2.0 x 105) was significantly higher as 
compared to PEI/siRNA/PEI-AuNPs (5.6 x 104), as determined by inductively coupled 
plasma spectroscopy (ICP-OES) and transmission electron micrographs of CHO-K1 
cells. Additionally, the electron micrographs of sectioned CHO-K1 cells demonstrated 
the intracellular fate of the AuNPs. AuNPs were predominantly trapped within 
endocytotic vesicles after 6 hours of incubation, and no particles were detected in the 
nucleus. It was of great importance to provide evidence of the activity of the siRNA 
inside the cells. Therefore, the functionality of the successfully coated AuNPs was 
determined by measuring the gene knockdown of nanoparticles in CHO-K1 cells 
stably expressing enhanced green fluorescent protein (CHO-K1/EGFP). A dose 
dependent knockdown was measured for PEI/siRNA/PEI-AuNPs and the cellular 
EGFP production was reduced to about 28 %. The technique showed highly specific 
gene silencing and the cell viability of CHO-K1/EGFP cells was about 95 %. In 
contrast, no silencing efficacy was detected when siRNA was used as the top layer, 
which could be attributed to the degradation of unprotected siRNA on the surface of 
the nanoparticles. 
Lastly, we showed how size influences the cellular uptake of nanoparticles and the 
amount of cargo molecules per cell. Different sizes of AuNPs (20, 30, 50 and 80 nm) 
were coated with PEI and 21 bp DNA via the LbL technique, and the 
physicochemical characteristics, as well as the stability of nanoparticles, were 
investigated. All the AuNPs of different sizes were successfully coated via the LbL 
approach and investigated for their physicochemical properties. The sizes of LbL-
coated AuNPs were 32, 38.7, 60.9, and 84.8 nm after the last coating step, and all 
LbL-coated nanoparticles showed a positive zeta potential. Additionally, all the LbL-
coated AuNPs showed good stability in culture medium containing serum. 
Afterwards, the proteins bound to the nanoparticle surface were investigated 
qualitatively, and the results showed a significant amount of different serum proteins 
adsorbed to the surface of LbL-coated AuNPs. This finding opens the way for further 
study to identify these protein types in future experiments. Additionally, the cellular 
uptake of different sized LbL-coated AuNPs was investigated. The investigation 
showed that the smaller AuNPs were taken up by the cells to a higher extent than 
larger ones. Moreover, there was a positive correlation between the amount of active 
substances taken up by the cells and the size of LbL-coated AuNPs. The number of 
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PEI as well as DNA molecules increased with the size of the AuNPs. Therefore, 
much smaller particles are necessary to deliver a similar amount of active molecules 
per cell. Furthermore, these LbL-coated AuNPs did not show any sign of toxicity to 
the cells at the concentrations applied during cellular uptake experiments, which is 
considered a prerequisite for future in vivo application. In summary, these results 
provide a better understanding of how the size of LbL-coated AuNP affects the 
cellular uptake, thereby determining the amount of cargo molecules per cell. (chapter 
5). 
 
Conclusion and outlook 
In conclusion, this thesis successfully demonstrated strategies for the highly efficient 
nucleic acid delivery via the LbL technique. This technique offers a unique 
opportunity to fabricate well-defined and homogenously distributed nano-carriers for 
siRNA delivery. The result showed how the surface properties and the size of LbL-
coated AuNPs had a great impact on their internalization. Therefore, this finding will 
assist in the future design of nano-structures delivering nucleic acids for biomedical 
applications. Moreover, this technique could be a good candidate for further 
investigation of cellular uptake and the specific pathways into cells, in order to deliver 
nucleic acid to specific intracellular destinations and determine the intracellular fate of 
nanoparticles. In future studies, the determination of the types of proteins adsorbed 
onto the surface of AuNPs is of great importance because the types of adsorbed 
protein differ with regard to the outer layer and affect the cellular uptake of 
nanoparticles. Here, protein identification could assist in making cellular uptake more 
specific. In addition, the surface of the LbL-coated AuNPs can be modified in order to 
prevent nonspecific uptake into cells via PEG modification. Afterwards, targeted 
delivery of nanoparticles into specific cells can be achieved via the attachment of 
targeting ligands onto the surface of these PEG modified nanoparticles. Overall, the 
LbL strategy presented here could be an excellent basis for future studies directed at 
specific cell targets. Last but not least, the success of this study opens the way 
towards the delivery of not only nucleic acid, but also other charged drug molecules 
into cells via LbL technology using AuNPs as a template. 
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Abbreviations 
λmax  Peak of maximum absorption 
ξ-potential zeta potential 
AuNP  gold nanoparticle 
AuNPs gold nanoparticles 
Ago2  argonaute 2  
AIDS   acquired immune deficiency syndrome 
AMD  age-related macular dgeneration 
bp   base pair 
C. elegans Caenorhabditis elegans 
CHO-K1  chinese hamster ovarian cell line 
CHS  chalcone synthetase 
CLSM  confocal laser scanning microscopy 
CO2   carbon dioxide 
DLS  dynamic light scattering 
DMEM  Dulbecco`s modified eagle`s medium 
DNA   deoxyribonucleic acid 
dsRNAs double-stranded RNAs 
DTT  dithiothreitol 
EGFP  enhanced green fluorescent protein 
FACS  fluorescence activated cell sorting 
FBS   fetal bovine serum 
GFP   green fluorescent protein 
Ham´s F-12  Nutrient Mixture F-12 
HCT 116 human colorectal carcinoma cell line 
HeLa   human cervical carcinoma cell line 
HCl   hydrochloric acid 
HNO3  nitric acid 
ICP-OES inductively coupled plasma-optical emission spectroscopy 
kDa   kilo Dalton 
LbL  Layer-by-Layer 
MEM  minimum essential medium 
mRNA messenger RNA 
MCF-7 human breast cancer cell line 
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MFI  mean fluorescence intensity 
MTT   [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] 
MUA  mercaptoundecanoic acid 
MUA-AuNPs mercaptoundecanoic acid stabilized gold nanoparticles 
Mw   molecular weight 
MWCO  molecular weight cut off 
NaOH  sodium hydroxide 
NP   the ratio of nitrogens in polymer to phosphates in DNA 
PAH  poly(allylamine hydrochloride) 
PBS   phosphate-buffered saline 
PEG  polyethylene glycol 
PEI   poly(ethylene imine) 
PI   polydispersity index 
PSS  poly(styrene sulfonate) 
PLL   poly(L-lysine) 
RISC  RNA-induced silencing complex 
RNAi  RNA interference 
RNA   ribonucleic acid 
rpm   rotations per minute 
RT  room temperature 
siRNA  short interfering RNA 
siRNAs short interfering RNAs 
SDS   sodium dodecyl sulfate 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SPR  surface plasmon resonance 
SF   serum free 
TEM  transmission electron microscopy 
TNBS  trinitrobenzenesulfonic acid 
UV   ultraviolett light or irradiation 
V  volt 
VEGF  vascular endothelial growth factor 
VEGFR vascular endothelial growth factor receptor 
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